1. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial. ITAC (INSIGHT 013) Study Group.
    Lancet. 2022:S0140-6736(22)00101-5. Abstract
  2. Achromobacter spp. in a Cohort of Non-Selected Pre- and Post-Lung Transplant Recipients. Crone CG, Rezahosseini O, Schultz HHL, Qvist T, Johansen HK, Nielsen SD, Perch M.
    Pathogens. 2022;11(2):181. Abstract
  3. Pneumocystis jirovecii pneumonia in liver transplant recipients in an era of routine prophylaxis. Andreasen PB, Rezahosseini O, Møller DL, Wareham NE, Thomsen MT, Houmami R, Knudsen AD, Knudsen J, Kurtzhals JAL, Rostved AA, Pedersen CR, Rasmussen A, Nielsen SD.
    Immun Inflamm Dis. 2022;10(1):93-100 Abstract
  4. Integrative Lipidomics and Metabolomics for System-Level Understanding of the Metabolic Syndrome in Long-Term Treated HIV-Infected Individuals. Olund Villumsen S, Benfeitas R, Knudsen AD, Gelpi M, Høgh J, Thomsen MT, Murray D, Ullum H, Neogi U, Nielsen SD.
    Front Immunol. 2022;12:742736. Abstract
  5. Identifying patients with chronic lymphocytic leukemia without need of treatment: End of endless watch and wait? Brieghel C, Galle V, Agius R, da Cunha-Bang C, Andersen MA, Vlummens P, Mattsson M, Rosenquist R, Smedby KE, Herling CD, Bahlo J, Hallek M, Lundgren JD, Offner F, Niemann CU.
    Eur J Haematol. 2022. Epub ahead of print. Abstract
  6. Prospective phase II trial of prognostication by 68Ga-NOTA-AE105 uPAR PET in patients with neuroendocrine neoplasms: Implications for uPAR targeted therapy. Carlsen EA, Loft M, Loft A, Berthelsen AK, Langer SW, Knigge U, Kjaer A.
    J Nucl Med. 2022:jnumed.121.263177. Abstract
  7. Activity Dose Reduction in 64Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Impact on Image Quality and Lesion Detection Ability. Loft M, Carlsen EA, Johnbeck CB, Jensen CV, Andersen FL, Langer SW, Oturai P, Knigge U, Kjaer A.
    Mol Imaging Biol. 2022. Epub ahead of print. Abstract
  8. Social distancing in relation to severe exacerbations of COPD - a nationwide semi-experimental study during the COVID-19 pandemic. Saeed MI, Sivapalan P, Eklöf J, Ulrik CS, Browatzki A, Weinreich UM, Jensen TT, Biering-Sørensen T, Jensen JS.
    Am J Epidemiol. 2022:kwab292. Abstract
  9. Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with chronic obstructive pulmonary disease. Eklöf J, Misiakou MA, Sivapalan P, Armbruster K, Browatzki A, Nielsen TL, Lapperre TS, Andreassen HF, Janner J, Ulrik CS, Gabrielaite M, Johansen HK, Jensen A, Nielsen TV, Hertz FB, Ghathian K, Calum H, Wilcke T, Seersholm N, Jensen JS, Marvig RL.
    Clin Microbiol Infect. 2022:S1198-743X(22)00041-6. Abstract
  10. Posttransplantation Diabetes Mellitus Among Solid Organ Recipients in a Danish Cohort. Dos Santos Q, Hornum M, Terrones-Campos C, Crone CG, Wareham NE, Soeborg A, Rasmussen A, Gustafsson F, Perch M, Soerensen SS, Lundgren J, Feldt-Rasmussen B, Reekie J.
    Transpl Int. 2022;35:10352. Abstract
  11. Risk of Bacterial, Viral, and Fungal Infections in Patients With Solid Malignant Tumors Treated With Curative Intent Radiation Therapy. Terrones-Campos C, Ledergerber B, Specht L, Vogelius IR, Helleberg M, Lundgren J.
    Adv Radiat Oncol. 2022;7(6):100950. Abstract
  12. Patients with CLL have lower risk of death from COVID-19 in the omicron era. Niemann CU, da Cunha-Bang C, Helleberg M, Ostrowski SR, Brieghel C.
    Blood. 2022:blood.2022016147. Abstract
  13. The gut microbiome in patients with chronic lymphocytic leukemia. Faitová T, Svanberg R, Da Cunha-Bang C, Ilett EE, Jørgensen M, Noguera-Julian M, Paredes R, MacPherson CR, Niemann CU.
    Haematologica. 2022. Epub ahead of print. Abstract
  14. Increased incidence rates of positive blood cultures shortly after chemotherapy compared to radiotherapy among individuals treated for solid malignant tumours. Roen A, Terrones C, Bannister W, Helleberg M, Andersen MA, Niemann CU, Daugaard G, Specht L, Mocroft A, Reekie J, Lundgren J.
    Infection. 2022. Epub ahead of print. Abstract
  15. Pre-transplantation vitamin E levels and acute graft-versus-host disease after non-myeloablative allogeneic hematopoietic cell transplantation. Gjærde LK, Ostrowski SR, Jørgensen NR, Schierbeck F, Andersen NS, Friis LS, Kornblit B, Petersen SL, Schjødt I, Sengeløv H.
    Transpl Immunol. 2022;74:101650. Abstract
  16. Development and Validation of a Risk Score for Post-Transplant Lymphoproliferative Disorders among Solid Organ Transplant Recipients. Dos Santos Q, Wareham NE, Mocroft A, Rasmussen A, Gustafsson F, Perch M, Sørensen SS, Manuel O, Müller NJ, Lundgren J, Reekie J.
    Cancers (Basel). 2022;14(13):3279. Abstract
  17. Early- and late-onset posttransplant lymphoproliferative disorders among adult kidney and liver transplant recipients. Abdulovski R, Møller DL, Knudsen AD, Sørensen SS, Rasmussen A, Nielsen SD, Wareham NE.
    Eur J Haematol. 2022. Epub ahead of print. Abstract
  18. Validation of cause of death classification after heart transplantation and cause-specific life expectancy compared to the general population. Gjesdal G, Lundgren J, Czuba T, Wareham NE, Gustafsson F, Nilsson J, Smith JG, Braun OÖ.
    Clin Transplant. 2022:e14756. Epub ahead of print. Abstract
  19. Trends in underlying causes of death in solid organ transplant recipients between 2010 and 2020: Using the CLASS method for determining specific causes of death. Søborg A, Reekie J, Rasmussen A, Cunha-Bang CD, Gustafsson F, Rossing K, Perch M, Krohn PS, Sørensen SS, Lund TK, Sørensen VR, Ekenberg C, Lundgren L, Lodding IP, Moestrup KS, Lundgren J, Wareham NE.
    PLoS One. 2022;17(7):e0263210. Abstract
  20. Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial. ACTIV-3–Therapeutics for Inpatients with COVID-19 (TICO) Study Group.
    Lancet Respir Med. 2022:S2213-2600(22)00215-6. Abstract
  21. Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial. ACTIV-3/TICO Bamlanivimab Study Group, Lundgren JD, Grund B, Barkauskas CE, Holland TL, Gottlieb RL, Sandkovsky U, Brown SM, Knowlton KU, Self WH, Files DC, Jain MK, Benfield T, Bowdish ME, Leshnower BG, Baker JV, Jensen JU, Gardner EM, Ginde AA, Harris ES, Johansen IS, Markowitz N, Matthay MA, Østergaard L, Chang CC, Goodman AL, Chang W, Dewar RL, Gerry NP, Higgs ES, Highbarger H, Murray DD, Murray TA, Natarajan V, Paredes R, Parmar MKB, Phillips AN, Reilly C, Rupert AW, Sharma S, Shaw-Saliba K, Sherman BT, Teitelbaum M, Wentworth D, Cao H, Klekotka P, Babiker AG, Davey VJ, Gelijns AC, Kan VL, Polizzotto MN, Thompson BT, Lane HC, Neaton JD.
    Ann Intern Med. 2022;175(2):234-243. Abstract
  22. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial. ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study Group.
    Lancet Infect Dis. 2022;22(5):622-635. Abstract
  23. Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery. Douin DJ, Siegel L, Grandits G, Phillips A, Aggarwal NR, Baker J, Brown SM, Chang CC, Goodman AL, Grund B, Higgs ES, Hough CL, Murray DD, Paredes R, Parmar M, Pett S, Polizzotto MN, Sandkovsky U, Self WH, Young BE, Babiker AG, Davey VJ, Kan V, Gelijns AC, Matthews G, Thompson BT, Lane HC, Neaton JD, Lundgren JD, Ginde AA; ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study Group.
    Am J Respir Crit Care Med. 20227. Epub ahead of print. Abstract
  24. RAGE has potential pathogenetic and prognostic value in nonintubated hospitalized patients with COVID-19. Wick KD, Siegel L, Neaton JD, Oldmixon C, Lundgren J, Dewar RL, Lane HC, Thompson BT, Matthay MA; ACTIV-3/TICO study group.
    JCI Insight. 2022;7(9):e157499. Abstract
  25. Patients with CLL have a lower risk of death from COVID-19 in the Omicron era. Blood. Niemann CU, da Cunha-Bang C, Helleberg M, Ostrowski SR, Brieghel C.
    Blood. 2022;140(5):445-450. Abstract
  26. Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial. ACTIV-3/TICO Study Group.
    Ann Intern Med. 2022. Epub ahead of print. Abstract
  27. Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO). Mylonakis E, Lutaakome J, Jain MK, Rogers AJ, Moltó J, Benet S, Mourad A, Files DC, Mugerwa H, Kityo C, Kiweewa F, Nalubega MG, Kitonsa J, Nabenkema E, Murray DD, Braun D, Kamel D, Higgs ES, Hatlen TJ, Kan VL, Sanchez A, Tierney J, Denner E, Wentworth D, Babiker AG, Davey VJ, Gelijns AC, Matthews GV, Thompson BT, Lane HC, Neaton JD, Lundgren JD.
    Med (N Y). 2022;3(8):531-53 Abstract
  28. Personalized survival probabilities for SARS-CoV-2 positive patients by explainable machine learning. Zucco AG, Agius R, Svanberg R, Moestrup KS, Marandi RZ, MacPherson CR, Lundgren J, Ostrowski SR, Niemann CU.
    Sci Rep. 2022;12(1):13879. Abstract
  29. Readmissions, post-discharge mortality and sustained recovery among patients admitted to hospital with COVID-19.  Moestrup KS, Reekie J, Zucco AG, Jensen TØ, Jensen JUS, Wiese L, Ostrowski SR, Niemann CU, MacPherson C, Lundgren J, Helleberg M.
    Clin Infect Dis. 2022:ciac639. Epub ahead of print. Abstract
  30. The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19. ACTIV-3/TICO Study Group.
    Ann Intern Med. 2022. Epub ahead of print. Epub ahead of print. Abstract
  31. Post-Transplantation Anemia and Risk of Death Following Lung Transplantation. Bugge TB, Perch M, Rezahosseini O, Crone CG, Jensen K, Schultz HH, Bredahl P, Hornum M, Nielsen SD, Lund TK.
    Transplant Proc. 2022:S0041-1345(22)00508-5. Abstract
  32. Added Value of Reanalysis of Whole Exome- and Whole Genome Sequencing Data From Patients Suspected of Primary Immune Deficiency Using an Extended Gene Panel and Structural Variation Calling. Mørup SB, Nazaryan-Petersen L, Gabrielaite M, Reekie J, Marquart HV, Hartling HJ, Marvig RL, Katzenstein TL, Masmas TN, Lundgren J, Murray DD, Helleberg M, Borgwardt L.
    Front Immunol. 2022;13:906328. Abstract
  33. Development of a 64Cu-labeled CD4+ T cell targeting PET tracer: evaluation of CD4 specificity and its potential use in collagen-induced arthritis. Clausen AS, Christensen C, Christensen E, Cold S, Kristensen LK, Hansen AE, Kjaer A.
    EJNMMI Res. 2022;12(1):62. Abstract
  34. Metabolic Potential of the Gut Microbiome Is Significantly Impacted by Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation Recipients. Jørgensen M, Nørgaard JC, Ilett EE, Marandi RZ, Noguera-Julian M, Paredes R, Murray DD, Lundgren J, MacPherson CR, Sengeløv H.
    Int J Mol Sci. 2022;23(19):11115. Abstract
  35. Pre-Transplantation Plasma ST2 Level as a Prognostic Biomarker of 1-Year Non-Relapse Mortality in Allogeneic Hematopoietic Cell Transplantation. Gjærde LK, Ostrowski SR, Schierbeck F, Andersen NS, Friis LS, Kornblit B, Petersen SL, Schjødt I, Sengeløv H.
    Transplant Cell Ther. 2022:S2666-6367(22)01773-0. Abstract
  36. Chest x-ray imaging score is associated with severity of COVID-19 pneumonia: the MBrixia score. CJensen CM, Costa JC, Nørgaard JC, Zucco AG, Neesgaard B, Niemann CU, Ostrowski SR, Reekie J, Holten B, Kalhauge A, Matthay MA, Lundgren JD, Helleberg M, Moestrup KS.
    Sci Rep. 2022;12(1):21019.  Abstract


  1. Transmission and antibiotic resistance of Achromobacter in cystic fibrosis. Gabrielaite M, Bartell JA, Nørskov-Lauritsen N, Pressler T, Nielsen FC, Johansen HK, Marvig RL.
    J Clin Microbiol. 2021:JCM.02911-20. Abstract
  2. Omics-based tracking of Pseudomonas aeruginosa persistence in "eradicated" cystic fibrosis patients. Bartell JA, Sommer LM, Marvig RL, Skov M, Pressler T, Molin S, Johansen HK.
    Eur Respir J. 2021;57(4):2000512. Abstract
  3. Incidence and impact of parvovirus B19 infection in seronegative solid organ transplant recipients. Rezahosseini O, Ekenberg C, Møller DL, Sørensen SS, Wareham NE, Perch M, Gustafsson F, Rasmussen A, Kirkby N, Reekie J, Lundgren J, Nielsen SD.
    J Infect Dis. 2021:jiab024. Abstract
  4. Functional immune reconstitution early after allogeneic haematopoietic cell transplantation: A comparison of pre- and post-transplantation cytokine responses in stimulated whole blood. Gjaerde LK, Brooks PT, Andersen NS, Friis LS, Kornblit B, Petersen SL, Schjødt I, Nielsen SD, Ostrowski SR, Sengeløv H.
    Scand J Immunol. 2021:e13042. Abstract
  5. Hematological toxicity in patients with solid malignant tumors treated with radiation - Temporal analysis, dose response and impact on survival. Terrones-Campos C, Ledergerber B, Vogelius IR, Helleberg M, Specht L, Lundgren J.
    Radiother Oncol. 2021;158:175-183. Abstract
  6. The association of human leukocyte antigen alleles with clinical disease progression in HIV-positive cohorts with varied treatment strategies. Ekenberg C, Reekie J, Zucco AG, Murray DD, Sharma S, Macpherson CR, Babiker A, Kan V, Lane HC, Neaton JD, Lundgren JD; INSIGHT START, SMART Study Groups.
    AIDS. 2021;35(5):783-789. Abstract
  7. Cost-effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States. Boettiger DC, Newall AT, Phillips A, Bendavid E, Law MG, Ryom L, Reiss P, Mocroft A, Bonnet F, Weber R, El-Sadr W, d'Arminio Monforte A, de Wit S, Pradier C, Hatleberg CI, Lundgren J, Sabin C, Kahn JG, Kazi DS.
    J Int AIDS Soc. 2021;24(3):e25690. Abstract
  8. Transmitted HIV-1 drug resistance in a large international cohort using next-generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) study. Baxter JD, Dunn D, Tostevin A, Marvig RL, Bennedbaek M, Cozzi-Lepri A, Sharma S, Kozal MJ, Gompels M, Pinto AN, Lundgren J; INSIGHT START Study Group.
    HIV Med. 2021;22(5):360-371. Abstract
  9. ABO blood types and sepsis mortality. Itenov TS, Sessler DI, Khanna AK, Ostrowski SR, Johansson PI, Erikstrup C, Pedersen OB, Rygård SL, Holst LB, Bestle MH, Hein L, Lindhardt A, Tousi H, Andersen MH, Mohr T, Lundgren JD, Jensen JU.
    Ann Intensive Care. 2021;11(1):61. Abstract
  10. Human immunotypes impose selection on viral genotypes through viral epitope specificity. Gabrielaite M, Bennedbæk M, Zucco AG, Ekenberg C, Murray DD, Kan VL, Touloumi G, Vandekerckhove L, Turner D, Neaton J, Lane HC, Safo S, Arenas-Pinto A, Polizzotto MN, Günthard HF, Lundgren JD, Marvig RL; INSIGHT START trial group.
    J Infect Dis. 2021:jiab253. Epub ahead of print. Abstract
  11. Genomic and Phenotypic Evolution of Achromobacter xylosoxidans during Chronic Airway Infections of Patients with Cystic Fibrosis. Khademi SMH, Gabrielaite M, Paulsson M, Knulst M, Touriki E, Marvig RL, Påhlman LI.
    mSystems. 2021:e0052321. Abstract
  12. Achromobacter spp. genetic adaptation in cystic fibrosis. Gabrielaite M, Nielsen FC, Johansen HK, Marvig RL.
    Microb Genom. 2021 Jul;7(7). Abstract
  13. Platelet and Red Blood Cell Transfusions and Risk of Acute Graft-versus-Host Disease after Myeloablative Allogeneic Hematopoietic Cell Transplantation. Gjærde LK, Sørensen ALT, Hjorth von Stemann J, Fischer-Nielsen A, Hansen MB, Sengeløv H, Ostrowski SR.
    Transplant Cell Ther. 2021 Jul 9:S2666-6367(21)01036-8. Abstract
  14. Pre-transplantation plasma vitamin D levels and acute graft-versus-host disease after myeloablative hematopoietic cell transplantation in adults. Gjærde LK, Ostrowski SR, Andersen NS, Friis LS, Kornblit B, Petersen SL, Schjødt I, Sengeløv H.
    Transpl Immunol. 2021 Jul 15;68:101437. Epub ahead of print. Abstract
  15. Phylogenetic analysis of HIV-1 shows frequent cross-country transmission and local population expansions.  Bennedbæk M, Zhukova A, Tang ME, Bennet J, Munderi P, Ruxrungtham K, Gisslen M, Worobey M, Lundgren JD, Marvig RL.
    Virus Evol. 2021 Jun 9;7(2):veab055. Abstract
  16. Bacterial and fungal bloodstream infections in solid organ transplant recipients: results from a Danish cohort with nationwide follow-up. Møller DL, Sørensen SS, Perch M, Gustafsson F, Rezahosseini O, Knudsen AD, Scheike T, Knudsen JD, Lundgren J, Rasmussen A, Nielsen SD.
    Clin Microbiol Infect. 2021 Jul 27:S1198-743X(21)00413-4. Epub ahead of print. Abstract
  17. Development and Dynamics of Cytomegalovirus UL97 Ganciclovir Resistance Mutations in Transplant Recipients Detected by Next-Generation Sequencing. Lodding IP, Jørgensen M, Bennedbæk M, Kirkby N, Naegele K, Gustafsson F, Perch M, Rasmussen A, Sengeløv H, Sørensen SS, Hirsch HH, Lundgren JD.
    Open Forum Infect Dis. 2021 Sep 4;8(10):ofab462. Abstract
  18. Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3). Murray DD, Babiker AG, Baker JV, Barkauskas CE, Brown SM, Chang CC, Davey VJ, Gelijns AC, Ginde AA, Grund B, Higgs E, Hudson F, Kan VL, Lane HC, Murray TA, Paredes R, Parmar MK, Pett S, Phillips AN, Polizzotto MN, Reilly C, Sandkovsky U, Sharma S, Teitelbaum M, Thompson BT, Young BE, Neaton JD, Lundgren JD.
    Clin Trials. 2021 Oct 10:17407745211049829. Epub ahead of print. Abstract
  19. The central role of the glutamate metabolism in long-term antiretroviral treated HIV-infected individuals with metabolic syndrome. Gelpi M, Mikaeloff F, Knudsen AD, Benfeitas R, Krishnan S, Svenssson Akusjärvi S, Høgh J, Murray DD, Ullum H, Neogi U, Nielsen SD.
    Aging (Albany NY). 2021 Oct 11;13(19):22732-22751. Abstract
  20. Pulmonary mucormycosis in the aftermath of critical COVID-19 in an immunocompromised patient: Mind the diagnostic gap. Crone CG, Helweg-Larsen J, Steensen M, Arendrup MC, Helleberg M.
    J Mycol Med. 2021;32(1):101228. Abstract
  21. An Observational Prospective Cohort Study of Incidence and Outcome of Streptococcus pneumoniae and Hemophilus influenzae Infections in Adult Solid Organ Transplant Recipients. Rezahosseini O, Møller DL, Sørensen SS, Perch M, Gustafsson F, Gelpi M, Knudsen J, Helleberg M, Rasmussen A, Nielsen SD, Harboe ZB.
    Microorganisms. 2021;9(7):1371. Abstract
  22. Bloodstream infections in head and neck cancer patients after curative-intent radiotherapy: a population-based study from the Danish Head and Neck Cancer Group database. Jensen KH, Vogelius I, Moser CE, Andersen E, Eriksen JG, Johansen J, Farhadi M, Andersen M, Overgaard J, Friborg J.
    Br J Cancer. 2021;125(3):458-464. Abstract
  23. Initial Experience with 64Cu-DOTATATE Digital PET of Patients with Neuroendocrine Neoplasms: Comparison with Analog PET. Loft M, Johnbeck CB, Carlsen EA, Johannesen HH, Oturai P, Langer SW, Knigge U, Kjaer A.
    Diagnostics (Basel). 2021;11(2):350. Abstract
  24. Cytokine autoantibodies are stable throughout the haematopoietic stem cell transplantation course and are associated with distinct biomarker and blood cell profiles. von Stemann JH, Gjærde LK, Haastrup EK, Minculescu L, Brooks PT, Sengeløv H, Hansen MB, Ostrowski SR.
    Sci Rep. 2021;11(1):23971. Abstract
  25. Dissection of the Activity of Agricultural Fungicides against Clinical Aspergillus Isolates with and without Environmentally and Medically Induced Azole Resistance. Jørgensen KM, Helleberg M, Hare RK, Jørgensen LN, Arendrup MC.
    J Fungi (Basel). 2021;7(3):205. Abstract
  26. Response to Aviv et al. Helleberg M, Niemann CU, Moestrup KS, Kirk O, Lebech AM, Lundgren J.
    J Infect Dis. 2021;224(3):559-561. Abstract
  27. Photothermal Therapy as Adjuvant to Surgery in an Orthotopic Mouse Model of Human Fibrosarcoma. Simón M, Jørgensen JT, Melander F, Andresen TL, Christensen A, Kjaer A.
    Cancers (Basel). 2021;13(22):5820. Abstract
  28. uPAR PET/CT for Prognostication and Response Assessment in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing Radium-223 Therapy: A Prospective Phase II Study. Fosbøl MØ, Mortensen J, Petersen PM, Loft A, Madsen J, Kjaer A.
    Diagnostics (Basel). 2021;11(6):1087. Abstract
  29. Antimicrobial use before chronic lymphocytic leukemia: a retrospective cohort study. Andersen MA, Rostgaard K, Niemann CU, Hjalgrim H.
    Leukemia. 2021;35(3):747-751. Abstract
  30. Differences and Temporal Changes in Risk of Invasive Pneumococcal Disease in Adults with Hematological Malignancies: Results from a Nationwide 16-Year Cohort Study. Andersen MA, Niemann CU, Rostgaard K, Dalby T, Sørrig R, Weinberger DM, Hjalgrim H, Harboe ZB.
    Clin Infect Dis. 2021;72(3):463-471. Abstract
  31. Measles, Mumps, Rubella, and Varicella Zoster Virus Serology and Infections in Solid Organ Transplant Recipients During the First Year Posttransplantation. Rezahosseini O, Sørensen SS, Perch M, Ekenberg C, Møller DL, Knudsen AD, Kirkby N, Lundgren J, Lodding IP, Wareham NE, Gustafsson F, Rasmussen A, Nielsen SD.
    Clin Infect Dis. 2021;73(11):e3733-e3739. Abstract
  32. The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study. Mocroft A, Miro JM, Wandeler G, Llibre JM, Boyd A, van Bremen K, Beniowski M, Mikhalik J, Cavassini M, Maltez F, Duvivier C, Uberti Foppa C, Knysz B, Bakowska E, Kuzovatova E, Domingo P, Zagalo A, Viard JP, Degen O, Milinkovic A, Benfield T, Peters L; EuroSIDA study group.
    HIV Med. 2021. Epub ahead of print. Abstract
  33. Bacterial and fungal bloodstream infections in pediatric liver and kidney transplant recipients. Møller DL, Sørensen SS, Wareham NE, Rezahosseini O, Knudsen AD, Knudsen JD, Rasmussen A, Nielsen SD.
    BMC Infect Dis. 2021;21(1):541. Abstract
  34. Stimulated Immune Response by TruCulture® Whole Blood Assay in Patients With European Lyme Neuroborreliosis: A Prospective Cohort Study. Ørbæk M, Gynthersen RMM, Mens H, Stenør C, Wiese L, Brandt C, Ostrowski SR, Nielsen SD, Lebech AM.
    Front Cell Infect Microbiol. 2021;11:666037. Abstract


  1. Prevalence and Risk Factors of Moderate to Severe Hepatic Steatosis in HIV Infection: The Copenhagen Co-Morbidity Liver Study . Kirkegaard-Klitbo, D. M., Fuchs, A., Stender, S., Sigvardsen, P. E., Kühl, J. T., Kofoed, K. F., Køber, L., Nordestgaard, B. G., Bendtsen, F., Mocroft, A., Lundgren, J., Nielsen, S. D., Benfield, T.
    The Journal of infectious diseases. 2020. Abstract
  2. Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment
    Mocroft A, Lundgren J, Gerstoft J, Rasmussen LD, Bhagani S, Aho I, Pradier C, Bogner JR, Mussini C, Uberti Foppa C, Maltez F, Laguno M, Wandeler G, Falconer K, Trofimova T, Borodulina E, Jevtovic D, Bakowska E, Kase K, Kyselyova G, Haubrich R, Rockstroh JK, Peters L; EuroSIDA Study.
    Clin Infect Dis. 2020;70(10):2131-2140. Abstract
  3. Mortality and admission to intensive care units after febrile neutropenia in patients with cancer. Aagaard, T., Reekie, J., Jørgensen, M., Roen, A., Daugaard, G., Specht, L., Sengeløv, H., Mocroft, A., Lundgren, J., Helleberg, M.
    Cancer Medicine, 2020;9(9):3033-3042. Abstract
  4. Lymphopenia and neutropenia are associated with subsequent incident proteinuria in Danish patients with systemic lupus erythematosus . Tanha, N., Hansen, R. B., Yang, J., Lange, T., Nielsen, C. T., Helleberg, M., Kamper, A., Faurschou, M., Jacobsen, S.
    Scand J Rheumatol. 2020;49(2):122-130. Abstract
  5. Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines. Phillips, A. N., Bansi-Matharu, L., Venter, F., Havlir, D., Pozniak, A., Kuritzkes, D. R., Wensing, A., Lundgren, J. D., Pillay, D., Mellors, J., Cambiano, V., Jahn, A., Apollo, T., Mugurungi, O., Ripin, D., Da Silva, J., Raizes, E., Ford, N., Siberry, G. K., Gupta, R. K., Barnabas, R., Revill, P., Cohn, J., Calmy, A., Bertagnolio, S.
    Lancet HIV. 2020;7(3):e193-e200. Abstract
  6. Prevalence of and Risk Factors for Low Bone Mineral Density Assessed by Quantitative Computed Tomography in People Living With HIV and Uninfected Controls.Thomsen, M. T., Wiegandt, Y. L., Gelpi, M., Knudsen, A. D., Fuchs, A., Sigvardsen, P. E., Kühl, J. T., Nordestgaard, B., Køber, L., Lundgren, J., Hansen, A. E., Kofoed, K. F., Jensen, J. B., Nielsen, S. D.
    J Acquir Immune Defic Syndr. 2020;83(2):165-172. Abstract
  7. Risk factors during pregnancy and birth-related complications in HIV-positive versus HIV-negative women in Denmark, 2002-2014. Ørbaek, M., Thorsteinsson, K., Moseholm Larsen, E., Katzenstein, T. L., Storgaard, M., Johansen, I. S., Pedersen, G., Bach, D., Helleberg, M., Weis, N., Lebech, A.
    HIV Med. 2020;21(2):84-95. Abstract
  8. Interstitial lung abnormalities in people with HIV infection and uninfected controls. Ronit, A., Benfield, T., Lundgren, J., Vestbo, J., Afzal, S., Nordestgaard, B. G., Kühl, J. T., Kofoed, K. F., Nielsen, S. D., Kristensen, T.
    J Infect Dis. 2020; 221(12):1973-1977. Abstract
  9. Machine learning can identify newly diagnosed patients with CLL at high risk of infection. Agius, R., Brieghel, C., Andersen, M. A., Pearson, A. T., Ledergerber, B., Cozzi-Lepri, A., Louzoun, Y., Andersen, C. L., Bergstedt, J., von Stemann, J. H., Jørgensen, M., Tang, M. E., Fontes, M., Bahlo, J., Herling, C. D., Hallek, M., Lundgren, J., MacPherson, C. R., Larsen, J., Niemann, C. U.
    Nat Commun. 2020;11(1):363. Abstract
  10. Development and validation of a cycle-specific risk score for febrile neutropenia during chemotherapy cycles 2-6 in patients with solid cancers: The CSR FENCE score. Aagaard T, Reekie J, Roen A, Daugaard G, Specht L, Sengeløv H, Mocroft A, Lundgren J, Helleberg M.
    Int J Cancer. 2020;146(2):321-328. Abstract
  11. Impact of Hiv-Related Gut Microbiota Alterations on Metabolic Comorbidities. Gelpi, M., Vestad, B., Hansen, S. H., Holm, K., Drivsholm, N., Goetz, A., Kirkby, N. S., Lindegaard, B., Lebech, A., Hoel, H., Michelsen, A. E., Ueland, T., Gerstoft, J., Lundgren, J., Hov, J. R., Nielsen, S. D., Trøseid, M.
    Clin Infect Dis. 2020. Abstract
  12. Abdominal adipose tissue is associated with alterations in tryptophan-kynurenine metabolism and markers of systemic inflammation in people with HIV. Gelpi, M., Ueland, P. M., Trøseid, M., Mocroft, A., Lebech, A., Ullum, H., Midttun, Ø., Lundgren, J., Nielsen, S. D., Copenhagen Comorbidity in HIV Infection (COCOMO) Study.
    J Infect Dis. 2020;221(3):419-427. Abstract
  13. Evaluation of an electronic, patient-focused management system aimed at preventing cytomegalovirus disease following solid organ transplantation. Ekenberg, C., da Cunha-Bang, C., Lodding, I. P., Sørensen, S. S., Sengeløv, H., Perch, M., Rasmussen, A., Gustafsson, F., Wareham, N. E., Kirkby, N., Kjaer, J., Helleberg, M., Reekie, J., Lundgren, J. D.
    Transpl Infect Dis. 2020. Abstract
  14. Tuberculosis among Patients Undergoing Solid Organ Transplantation or Dialysis in a Low-Endemic Country, 2004-2017. Helleberg, M., Cho, D., Ekenberg, C., Sørensen, S., Rix, M., Gustafsson, F., Rasmussen, A., Perch, M., Andersen, P. H. S., Lundgren, J. D., Andersen, A. B.
    Tuberc Res Treat. 2020. Abstract
  15. Variant in ERAP1 promoter region is associated with low expression in a patient with a Behçet-like MHC-I-opathy. Dimopoulou, C., Lundgren, J. D., Sundal, J., Ullum, H., Aukrust, P., Nielsen, F. C., Marvig, R. L.
    J Hum Genet. 2020;65(3):325-335. Abstract
  16. Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive persons. A Mocroft, L Ryom, C Oprea, Q Li, A Rauch, C Boesecke, V Uzdaviniene, D Sedlacek, JM. Llibre, K Lacombe,  LN. Nielsen,  Florence, I Aho, N Chkhartishvili, J Szlavik, G Dragovic, C Leen, H Sambatakou, T Staub, M Laguno, H Elinav, J Tomazic, L Peters, for the EuroSIDA study group
    AIDS. 2020;34(10):1485-1495. Abstract
  17. Cutaneous leishmaniasis with secondary mucosal disease in a traveller due to Leishmania (Viannia) braziliensis. Crone, C. G., Helleberg, M.
    Journal of Travel Medicine. 2020. Abstract
  18. Epidemiology of hepatitis E virus infection in a cohort of 4023 immunocompromised patients. Harritshøj, L. H., Hother, C. E., Sengeløv, H., Daugaard, G., Sørensen, S. S., Jacobsen, S., Perch, M., Holm, D. K., Sækmose, S. G., Aagaard, B., Erikstrup, C., Hogema, B. M., Lundgren, J. D. & Ullum, H
    Int J Infect Dis. 2020;91:188-195. Abstract
  19. GenAPI: a tool for gene absence-presence identification in fragmented bacterial genome sequences. Migle Gabrielaite, Rasmus L Marvig
    BMC Bioinformatics. 2020;21(1):320. Abstract
  20. Identifying cross-disease components of genetic risk across hospital data in the UK Biobank. Cortes A, Albers PK, Dendrou CA, Fugger L, McVean G
    Nat Genet. 2020;52(1):126-134. Abstract
  21. Invasive aspergillosis in patients with severe COVID-19 pneumonia. Helleberg M, Steensen M, Arendrup MC.
    Clin Microbiol Infect. 2020;S1198-743X(20)30474-2, Abstract
  22. Monitoring CD8a+ T Cell Responses to Radiotherapy and CTLA-4 Blockade Using [64Cu]NOTA-CD8a PET Imaging. Kristensen LK, Christensen C, Alfsen MZ, Cold S, Nielsen CH, Kjaer A.
    NMol Imaging Biol. 2020;22(4):1021-1030. Abstract
  23. Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy. Helleberg M, Niemann CU, Moestrup KS, Kirk O, Lebech AM, Lane C, Lundgren J.
    J Infect Dis. 2020;222(7):1103-1107. Abstract
  24. Primary ciliary dyskinesia patients have the same P. aeruginosa clone in sinuses and lungs. Arndal E, Johansen HK, Haagensen JAJ, Bartell JA, Marvig RL, Alanin M, Aanæs K, Høiby N, Nielsen KG, Backer V, von Buchwald C.
    Eur Respir J. 2020;55(1):1901472. Abstract
  25. Rezafungin In Vitro Activity against Contemporary Nordic Clinical Candida Isolates and Candida auris Determined by the EUCAST Reference Method. Helleberg M, Jørgensen KM, Hare RK, Datcu R, Chowdhary A, Arendrup MC.
    Antimicrob Agents Chemother. 2020;64(4):e02438-19. Abstract
  26. Role of inflammatory biomarkers in the prevalence and incidence of hypertension among HIV-positive participants in the START trial. Ghazi L, Baker JV, Sharma S, Jain MK, Palfreeman A, Necsoi C, Murray DD, Neaton JD, Drawz PE for the INSIGHT START study group. 
    Am J Hypertens 2020; 33(1):43–52. Abstract
  27. Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients. Ilett EE, Jørgensen M, Noguera-Julian M, Nørgaard JC, Daugaard G, Helleberg M, Paredes R, Murray DD, Lundgren J, MacPherson C, Reekie J, Sengeløv H. 
    Blood Adv. 2020;4(22):5797-5809. Abstract
  28. Gene Loss and Acquisition in Lineages of Pseudomonas aeruginosa Evolving in Cystic Fibrosis Patient Airways. Gabrielaite M, Johansen HK, Molin S, Nielsen FC, Marvig RL.
    mBio. 2020;11(5):e02359-20.Abstract
  29. Genetic relationship between bacteria isolated from intraoperative air samples and surgical site infections at a major teaching hospital in Ghana. Stauning MA, Bediako-Bowan A, Bjerrum S, Andersen LP, Andreu-Sánchez S, Labi AK, Kurtzhals JAL, Marvig RL, Opintan JA.
    J Hosp Infect. 2020;104(3):309-320. Abstract
  30. Pretransplantation vitamin A plasma levels and risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. Gjærde LK, Andersen NS, Friis LS, Kornblit B, Petersen SL, Schjødt I, Ostrowski SR, Sengeløv H.
    Bone Marrow Transplant. 2020;55(7):1457-1459. . Abstract
  31. Vitamin E and acute graft-versus-host disease after myeloablative allogeneic hematopoietic cell transplantation. Gjaerde LK, Ostrowski SR, Minculescu L, Andersen NS, Friis LS, Kornblit B, Petersen SL, Schjødt I, Sengeløv H.
    Eur J Haematol. 2020 Dec 12. Abstract
  32. A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19. ACTIV-3/TICO LY-CoV555 Study Group, Lundgren JD, Grund B, Barkauskas CE, Holland TL, Gottlieb RL, Sandkovsky U, Brown SM, Knowlton KU, Self WH, Files DC, Jain MK, Benfield T, Bowdish ME, Leshnower BG, Baker JV, Jensen JU, Gardner EM, Ginde AA, Harris ES, Johansen IS, Markowitz N, Matthay MA, Østergaard L, Chang CC, Davey VJ, Goodman A, Higgs ES, Murray DD, Murray TA, Paredes R, Parmar MKB, Phillips AN, Reilly C, Sharma S, Dewar RL, Teitelbaum M, Wentworth D, Cao H, Klekotka P, Babiker AG, Gelijns AC, Kan VL, Polizzotto MN, Thompson BT, Lane HC, Neaton JD.
    N Engl J Med. 2020. Epub ahead of print. Abstract
  33. Nationwide germline whole genome sequencing of 198 consecutive pediatric cancer patients reveals a high incidence of cancer prone syndromes. Byrjalsen A, Hansen TVO, Stoltze UK, Mehrjouy MM, Barnkob NM, Hjalgrim LL, Mathiasen R, Lautrup CK, Gregersen PA, Hasle H, Wehner PS, Tuckuviene R, Sackett PW, Laspiur AO, Rossing M, Marvig RL, Tommerup N, Olsen TE, Scheie D, Gupta R, Gerdes AM, Schmiegelow K, Wadt K.
    PLoS Genet. 2020 Dec 17;16(12):e1009231. Abstract
  34. Altered immune reconstitution in HIV positive allogeneic stem cell transplant recipients. Murray DD, Zaunders J, Milliken ST, Munier CML, Ford C, Morrissey CO, Visweswaran M, Avery S, Sasadeusz J, Kwan J, Desai S, Law M, Koelsch KK, Lewin SR, Moore J, Kelleher AD, Polizzotto MN.
    Clin Infect Dis. 2020:ciaa748. Abstract
  35. Remdesivir for the Treatment of Covid-19 - Final Report. Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de Castilla D, Finberg RW, Dierberg K, Tapson V, Hsieh L, Patterson TF, Paredes R, Sweeney DA, Short WR, Touloumi G, Lye DC, Ohmagari N, Oh MD, Ruiz-Palacios GM, Benfield T, Fätkenheuer G, Kortepeter MG, Atmar RL, Creech CB, Lundgren J, Babiker AG, Pett S, Neaton JD, Burgess TH, Bonnett T, Green M, Makowski M, Osinusi A, Nayak S, Lane HC; ACTT-1 Study Group Members.
    N Engl J Med. 2020;383(19):1813-1826. Abstract
  36. Richter's transformation in patients with chronic lymphocytic leukaemia: a Nationwide Epidemiological Study. Ben-Dali Y, Hleuhel MH, da Cunha-Bang C, Brieghel C, Poulsen CB, Clasen-Linde E, Bentzen HHN, Frederiksen H, Christiansen I, Nielsen LH, Enggaard L, Helleberg M, Clausen M, Frederiksen M, Pedersen RS, Niemann CU, Andersen MA.
    Leuk Lymphoma. 2020;61(6):1435-1444. Abstract
  37. High Carriage Rates of Multidrug-Resistant Gram-Negative Bacteria in Neonatal Intensive Care Units From Ghana. Labi AK, Bjerrum S, Enweronu-Laryea CC, Ayibor PK, Nielsen KL, Marvig RL, Newman MJ, Andersen LP, Kurtzhals JAL.
    Open Forum Infect Dis. 2020;7(4):ofaa109. Abstract
  38. Oxacillinase-181 Carbapenemase-Producing Klebsiella pneumoniae in Neonatal Intensive Care Unit, Ghana, 2017-2019. Labi AK, Nielsen KL, Marvig RL, Bjerrum S, Enweronu-Laryea C, Bennedbæk M, Newman MJ, Ayibor PK, Andersen LP, Kurtzhals JAL.
    Emerg Infect Dis. 2020;26(9):2235-2238. Abstract
  39. Case Report: Hyper IgM Syndrome Identified by Whole Genome Sequencing in a Young Syrian Man Presenting With Atypical, Severe and Recurrent Mucosal Leishmaniasis. Drabe CH, Marvig RL, Borgwardt L, Lundgren JD, Maquart HVH, Katzenstein TL, Helleberg M.
    Front Immunol. 2020;11:567856. Abstract
  40. Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia. A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma. Andersen MA, Valentin R, Dissing Sjö L, Borgwardt L, Schmiegelow K, Andersen MK, Marvig RL, Yde CW, Niemann CU.
    Acta Oncol. 2020;59(12):1547-1551. Abstract
  41. Cancer during HIV infection. da Silva Neto MM, Brites C, Borges ÁH.
    APMIS. 2020;128(2):121-128. Abstract
  42. 64Cu-DOTATATE Positron Emission Tomography (PET) of Borrelia Burgdorferi Infection: In Vivo Imaging of Macrophages in Experimental Model of Lyme Arthritis. Skovsbo Clausen A, Ørbæk M, Renee Pedersen R, Oestrup Jensen P, Lebech AM, Kjaer A.
    Diagnostics (Basel). 2020;10(10):790. Abstract
  43. Cardiac chamber volumes and left ventricular mass in people living with HIV and matched uninfected controls. Krebs-Demmer L, Ronit A, Sigvardsen PE, Lebech AM, Gerstoft J, Knudsen AD, Fuchs A, Kühl JT, Nordestgaard BG, Kofoed KF, Nielsen SD.
    HIV Med. 2020;21(10):625-634. Abstract
  44. Real-world outcomes for 205 patients with chronic lymphocytic leukemia treated with ibrutinib. Aarup K, Rotbain EC, Enggaard L, Pedersen RS, Bergmann OJ, Thomsen RH, Frederiksen M, Frederiksen H, Nielsen T, Christiansen I, Andersen MA, Niemann CU.
    Eur J Haematol. 2020;105(5):646-654. Abstract
  45. Preoperative TruCulture® whole blood cytokine response predicts post-operative inflammation in pancreaticoduodenectomy patients-A pilot cohort study. Aasvang EK, Pitter S, Hansen CP, Storkholm JH, Krohn PS, Burgdorf SK, Von Stemann JH, Lundgren JD, Nielsen SD, Kehlet H, Ostrowski SR.
    Scand J Immunol. 2020;92(3):e12930. Abstract


1. Impact of CMV PCR Blips in Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation. IP Lodding, A Mocroft, C da Cunha Bang, F Gustafsson, M Iversen, N Kirkby, M Perch, A Rasmussen, H Sengeløv, S Sørensen, JD Lundgren.
Transplant Direct. 2018;4(6):e355. Abstract

2. Cessation of Cigarette Smoking and the Impact on Cancer Incidence in HIV-positive Persons: The D:A:D Study. Shepherd L, Ryom L, Law M, Petoumenos K, Hatleberg CI, d'Arminio Monforte A, Sabin C, Bower M, Bonnet F, Reiss P, de Wit S, Pradier C, Weber R, El-Sadr W, Lundgren J, Mocroft A; D:A:D Study group.
Clin Infect Dis. 2018 [Epub ahead of print] Abstract

3. DISSEQT - DIStribution based modeling of SEQuence space Time dynamics. Rasmus Henningsson, Gonzalo Moratorio, Antonio V Borderia, Marco Vignuzzi, Magnus Font.
bioRxiv, Posted May 21, 2018. Article

4. Extracorporeal photopheresis is a valuable treatment option in steroid-refractory or steroid-dependent acute graft versus host disease-experience with three different approaches. Nygaard M, Karlsmark T, Andersen NS, Schjødt IM, Petersen SL, Friis LS, Kornblit BT, Sengeløv H.
Bone Marrow Transplant. 2018 [Epub ahead of print] Abstract

5. Scale-up of HIV self-testing. Jakobsen SF, Raben D, Sperle I, Lazarus JV, James C, Mendão L, de Wit J, Platteau T, von Lingen AI, Corbelli GM, Antoniadi C, Casabona J, West B, Rockstroh J, Delpech V; HIV in Europe Steering Committee.
HIV Med. 2018. [Epub ahead of print] Abstract

6. SMSSVD - SubMatrix Selection Singular Value Decomposition. Henningsson R, Fontes M.
Bioinformatics. 2019 Feb 1;35(3):478-486. Abstract

7. The effect of interrupted/deferred antiretroviral therapy on disease risk: a SMART & START combined analysis. Borges ÁH, Neuhaus J, Sharma S, Neaton JD, Henry K, Anagnostou O, Staub T, Emery S, Lundgren JD; INSIGHT SMART & START Study Groups.
J Infect Dis. 2019 Jan 7;219(2):254-263. Abstract

8. A large-cohort, longitudinal study determines pre-cancer disease routes across different cancer types. Jessica X Hu, Marie Helleberg, Anders B Jensen, Søren Brunak and Jens Lundgren. 
Cancer Res. 2019 Feb 15;79(4):864-872. Abstract

9. Acute Lung Injury in Critically Ill Patients: Actin-Scavenger Gelsolin Signals Prolonged Respiratory Failure. Holm FS, Sivapalan P, Seersholm N, Itenov TS, Christensen PH, Jensen JS.
Shock. 2018 Oct 18. Abstract

10. Benefit of early versus deferred antiretroviral therapy on progression of liver fibrosis among people with HIV in the START randomized trial. Dharan NJ, Neuhaus J, Rockstroh JK, Peters L, Gordin F, Arenas-Pinto A, Emerson C, Marks K, Hidalgo J, Sarmento-Castro R, Stephan C, Kumarasamy N, Emery S, Matthews GV; INSIGHT START Study Group.
Hepatology. 2019 Mar;69(3):1135-1150. Abstract

11. Epidemiology of bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal nation-wide cohort study. Andersen MA, Moser CE, Lundgren J, Niemann CU.
Leukemia. 2019 Mar;33(3):662-670. Abstract

12. Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA. Amele S, Peters L, Sluzhynska M, Yakovlev A, Scherrer A, Domingo P, Gerstoft J, Viard JP, Gisinger M, Flisiak R, Bhaghani S, Ristola M, Leen C, Jablonowska E, Wandeler G, Stellbrink H, Falconer K, D'Arminio Monforte A, Horban A, Rockstroh JK, Lundgren JD, Mocroft A; EuroSIDA study group.
HIV Med. 2019 Apr;20(4):264-273. Abstract

13. Gut microbiome comparability of fresh-frozen versus stabilized-frozen samples from hospitalized 2 patients using 16S rRNA gene and shotgun metagenomic sequencing. Emma E. Ilett, Mette Jørgensen, Marc Noguera Julian, Gedske Daugaard, Daniel D. Murray, Marie Helleberg, Roger Paredes, Jens Lundgren, Henrik Sengeløv, Cameron MacPherson.
Scientific Reports 2019. Abstract

14. Incidence Rates and Risk Factors of Clostridioides difficile Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients. Ilett EE, Helleberg M, Reekie J, Murray DD, Wulff SM, Khurana MP, Mocroft A, Daugaard G, Perch M, Rasmussen A, Sørensen SS, Gustafsson F, Frimodt-Møller N, Sengeløv H, Lundgren J.
Open Forum Infect Dis. 2019 Feb 19;6(4):ofz086. Article

15. Limited anti-HIV neutralizing antibody breadth and potency before and after HIV superinfection in Danish men who have sex with men. Redd AD, Helleberg M, Sievers M, Schmidt SD, Doria-Rose NA, Bruno D, Traeger S, Martens C, Fonager J, Kronborg G, Packman Z, Mascola JR, Porcella SF, Gerstoft J, Quinn TC.
Infect Dis (Lond). 2019 Jan;51(1):56-61. Abstract

16. Prior exposure to thymidine analogs and didanosine is associated with long-lasting alterations in adipose tissue distribution and cardiovascular risk factors. Gelpi M, Afzal S, Fuchs A, Lundgren J, Knudsen AD, Drivsholm N, Mocroft A, Lebech AM, Lindegaard B, Kühl JT, Sigvardsen PE, Køber L, Nordestgaard BG, Kofoed KF, Nielsen SD.
AIDS. 2019 Mar 15;33(4):675-683. Abstract

17. Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use. Schuetz P, Beishuizen A, Broyles M, Ferrer R, Gavazzi G, Gluck EH, González Del Castillo J, Jensen JU, Kanizsai PL, Kwa ALH, Krueger S, Luyt CE, Oppert M, Plebani M, Shlyapnikov SA, Toccafondi G, Townsend J, Welte T, Saeed K
Clin Chem Lab Med. 2019 Feb 6. Abstract

18. Risk Factors for Low CD4+ Count Recovery Despite Viral Suppression among Participants Initiating Antiretroviral Treatment with CD4+ Counts > 500 cells/mm3: Findings from the Strategic Timing of AntiRetroviral Treatment (START) Trial. Boatman JA, Baker JV, Emery S, Furrer H, Mushatt DM, Sedlacek D, Lundgren JD, Neaton JD; INSIGHT START Study Group.
J Acquir Immune Defic Syndr. 2019 Jan 9. Abstract

19. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Alison J Rodger, Valentina Cambiano, Tina Bruun, Pietro Vernazza, Simon Collins, Olaf Degen, Giulio Maria Corbelli, Vicente Estrada, Anna Maria Geretti, Apostolos Beloukas, Dorthe Raben, Pep Coll, Andrea Antinori, Nneka Nwokolo, Armin Rieger, Jan M Prins, Anders Blaxhult, Rainer Weber, Arne Van Eeden, Norbert H Brockmeyer, Amanda Clarke, Jorge del Romero Guerrero, Francois Raffi, Johannes R Bogner, Gilles Wandeler, Jan Gerstoft, Felix Gutiérrez, Kees Brinkman, Maria Kitchen, Lars Ostergaard, Agathe Leon, Matti Ristola, Heiko Jessen, Hans-Jürgen Stellbrink, Andrew N Phillips, Jens Lundgren, for the PARTNER Study Group*
THE LANCET, 2019 May 2. Article

20. Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study. Phillips AN, Venter F, Havlir D, Pozniak A, Kuritzkes D, Wensing A, Lundgren JD, De Luca A, Pillay D, Mellors J, Cambiano V, Bansi-Matharu L, Nakagawa F, Kalua T, Jahn A, Apollo T, Mugurungi O, Clayden P, Gupta RK, Barnabas R, Revill P, Cohn J, Bertagnolio S, Calmy A.
Lancet HIV. 2019 Feb;6(2):e116-e127. Abstract

21. Lymphocyte Count Kinetics, Factors Associated with the End-of-Radiation-Therapy Lymphocyte Count, and Risk of Infection in Patients with Solid Malignant Tumors Treated with Curative-Intent Radiation Therapy. Terrones-Campos C, Ledergerber B, Vogelius IR, Specht L, Helleberg M, Lundgren J.
Int J Radiat Oncol Biol Phys. 2019 Nov 15;105(4):812-823. Abstract

22. Biomarker-assisted identification of sepsis-related acute liver impairment: a frequent and deadly condition in critically ill patients. Jensen JS, Peters L, Itenov TS, Bestle M, Thormar KM, Mohr TT, Lundgren B, Grarup J, Lundgren JD; Procalcitonin And Survival Study (PASS) Group.
Clin Chem Lab Med. 2019; 57(9):1422-1431 Abstract

23. Biomarkers of Acute Lung Injury The Individualized Approach: for Phenotyping, Risk Stratification and Treatment Surveillance. Murray DD, Itenov TS, Sivapalan P, Eklöf JV, Holm FS, Schuetz P, Jensen JU.
J Clin Med. 2019; 8(8). Abstract

24. Children exposed or unexposed to HIV: weight, height and BMI during the first five years of life. A Danish Nationwide Cohort Study. Moseholm E, Helleberg M, Sandholdt H, Katzenstein TL, Storgaard M, Pedersen G, Johansen IS, Weis N.
Clin Infect Dis. 2019. pii: ciz605. Abstract

25. COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 months. Sivapalan P, Ingebrigtsen TS, Rasmussen DB, Sørensen R, Rasmussen CM, Jensen CB, Allin KH, Eklöf J, Seersholm N, Vestbo J, Jensen JS.
BMJ Open Respir Res. 2019; 6(1):e000407. Abstract

26. Diagnostic Performance of T2Candida Among ICU Patients With Risk Factors for Invasive Candidiasis. Arendrup MC, Andersen JS, Holten MK, Krarup KB, Reiter N, Schierbeck J, Helleberg M.
Open Forum Infect Dis. 2019; 6(5):ofz136. Abstract

27. Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial. Sivapalan P, Lapperre TS, Janner J, Laub RR, Moberg M, Bech CS, Eklöf J, Holm FS, Armbruster K, Sivapalan P, Mosbech C, Ali AKM, Seersholm N, Wilcke JT, Brøndum E, Sonne TP, Rønholt F, Andreassen HF, Ulrik CS, Vestbo J, Jensen JS.
Lancet Respir Med. 2019; 7(8):699-709. Abstract

28. Hot topics on procalcitonin use in clinical practice, can it help antibiotic stewardship? Saeed K, González Del Castillo J, Backous C, Drevet S, Ferrer R, Gavazzi G, Gluck E, Jensen JU, Kanizsai P, Ruiz-Rodríguez JC, Molnar G, Fazakas J, Umpleby H, Townsend J, Schuetz P.
Int J Antimicrob Agents. 2019; 54(6):686-696. Abstract

29. Hyaluronic Acid Is a Biomarker for Allograft Dysfunction and Predicts 1-Year Graft Loss After Liver Transplantation. Rostved AA, Ostrowski SR, Peters L, Lundgren JD, Hillingsø J, Johansson PI, Rasmussen A.
Transplant Proc. 2018; 50(10):3635-3643. Abstract

30. Immune function as predictor of infectious complications and clinical outcome in patients undergoing solid organ transplantation (the ImmuneMo:SOT study): a prospective non-interventional observational trial. Drabe CH, Sørensen SS, Rasmussen A, Perch M, Gustafsson F, Rezahosseini O, Lundgren JD, Ostrowski SR, Nielsen SD.
BMC Infect Dis. 2019; 19(1):573. Abstract

31. Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation. Minculescu L, Marquart HV, Ryder LP, Andersen NS, Schjoedt I, Friis LS, Kornblit BT, Petersen SL, Haastrup E, Fischer-Nielsen A, Reekie J, Sengelov H.
Front Immunol. 2019;10:1997. Abstract

32. Increased Risk of Anemia, Neutropenia, and Thrombocytopenia in People With Human Immunodeficiency Virus and Well-Controlled Viral Replication. Akdag D, Knudsen AD, Thudium RF, Kirkegaard-Klitbo DM, Nielsen C, Brown P, Afzal S, Nordestgaard BG, Lundgren J, Nielsen SD.
J Infect Dis. 2019;220(11):1834-1842. Abstract

33. Long-lasting alterations in adipose tissue density and adiponectin production in people living with HIV after thymidine analogues exposure. Gelpi M, Knudsen AD, Larsen KB, Mocroft A, Lebech AM, Lindegaard B, Lundgren J, Kofoed KF, Nielsen SD; Copenhagen Comorbidity in HIV Infection (COCOMO) Study.
BMC Infect Dis. 2019;19(1):708. Abstract

34. Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study. Hatleberg CI, Ryom L, Kamara D, De Wit S, Law M, Phillips A, Reiss P, D'Arminio Monforte A, Mocroft A, Pradier C, Kirk O, Kovari H, Bonnet F, El-Sadr W, Lundgren JD, Sabin C; D:A:D Study Group.
EClinicalMedicine. 2019;13:91-100. Abstract

35. Prevalence and risk factors of prolonged QT interval and electrocardiographic abnormalities in persons living with HIV. Knudsen AD, Kofoed KF, Gelpi M, Sigvardsen PE, Mocroft A, Kühl JT, Fuchs A, Køber L, Nordestgaard BG, Benfield T, Graff C, Skov MW, Lundgren J, Nielsen SD; Copenhagen Comorbidity in HIV Infection (COCOMO) Study.
AIDS. 2019;33(14):2205-2210. Abstract

36. Prevalence of impaired renal function in virologically suppressed people living with HIV compared with controls: the Copenhagen Comorbidity in HIV Infection (COCOMO) study. Petersen N, Knudsen AD, Mocroft A, Kirkegaard-Klitbo D, Arici E, Lundgren J, Benfield T, Oturai P, Nordestgaard BG, Feldt-Rasmussen B, Nielsen SD, Ryom L.
HIV Med. 2019;20(10):639-647. Abstract

37. Primary ciliary dyskinesia patients have the same P. aeruginosa clone in sinuses and lungs. Arndal E, Johansen HK, Haagensen JAJ, Bartell JA, Marvig RL, Alanin M, Aanæs K, Høiby N, Nielsen KG, Backer V, von Buchwald C.
Eur Respir J. 2019 Sep 26. pii: 1901472. Abstract

38. Pseudomonas aeruginosa and risk of death and exacerbations in patients with chronic obstructive pulmonary disease: an observational cohort study of 22 053 patients. Eklöf J, Sørensen R, Ingebrigtsen TS, Sivapalan P, Achir I, Boel JB, Bangsborg J, Ostergaard C, Dessau RB, Jensen US, Browatzki A, Lapperre TS, Janner J, Weinreich UM, Armbruster K, Wilcke T, Seersholm N, Jensen JUS.
Clin Microbiol Infect. 2019. pii: S1198-743X(19)30336-2. Abstract

39. Serious clinical events in HIV-positive persons with chronic kidney disease. Ryom L, Lundgren JD, Law M, Kirk O, El-Sadr W, Bonnet F, Weber R, Fontas E, Monforte AD, Phillips A, Reiss P, de Wit S, Hatleberg CI, Sabin C, Mocroft A; D:A:D study group.
AIDS. 2019;33(14):2173-2188. Abstract

40. Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial. Ekenberg C, Tang ME, Zucco AG, Murray DD, MacPherson CR, Hu X, Sherman BT, Losso MH, Wood R, Paredes R, Molina JM, Helleberg M, Jina N, Kityo CM, Florence E, Polizzotto MN, Neaton JD, Lane HC, Lundgren JD; INSIGHT START Study Group.
J Infect Dis. 2019;220(8):1325-1334. Abstract

41. Uptake and effectiveness of two-drug compared with three-drug antiretroviral regimens among HIV-positive individuals in Europe. Neesgaard B, Pelchen-Matthews A, Ryom L, Florence E, Peters L, Roen A, Svedhem V, Clarke A, Benfield T, Mitsura V, Moreno S, Beniowski M, Begovac J, Matulionyte R, Trofimova T, Elbirt D, Kundro M, Vullo V, Behrens G, Staub T, Ragone L, Vannappagari V, Lundgren J, Mocroft A; EuroSIDA study.
AIDS. 2019;33(13):2013-2024. Abstract

42. Use of Contemporary Protease Inhibitors and Risk of Incident Chronic Kidney Disease in Persons With Human Immunodeficiency Virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study. Ryom L, Lundgren J, Reiss P, Kirk O, Law M, Ross M, Morlat P, Andreas Fux C, Fontas E, De Wit S, D'Arminio Monforte A, El-Sadr W, Phillips A, Ingrid Hatleberg C, Sabin C, Mocroft A; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group.
J Infect Dis. 2019;220(10):1629-1634. Abstract

43. Abdominal adipose tissue is associated with alterations in tryptophan-kynurenine metabolism and markers of systemic inflammation in people with HIV. Gelpi M, Ueland PM, Trøseid M, Mocroft A, Lebech AM, Ullum H, Midttun Ø, Lundgren J, Nielsen SD; Copenhagen Comorbidity in HIV Infection (COCOMO) Study.
J Infect Dis. 2019. pii: jiz465. Abstract

44. Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial. Davey RT Jr, Fernández-Cruz E, Markowitz N, Pett S, Babiker AG, Wentworth D, Khurana S, Engen N, Gordin F, Jain MK, Kan V, Polizzotto MN, Riska P, Ruxrungtham K, Temesgen Z, Lundgren J, Beigel JH, Lane HC, Neaton JD; INSIGHT FLU-IVIG Study Group.
Lancet Respir Med. 2019;7(11):951-963. Abstract

45. Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials. Chemaly RF, Chou S, Einsele H, Griffiths P, Avery R, Razonable RR, Mullane KM, Kotton C, Lundgren J, Komatsu TE, Lischka P, Josephson F, Douglas CM, Umeh O, Miller V, Ljungman P; Resistant Definitions Working Group of the Cytomegalovirus Drug Development Forum.
Clin Infect Dis. 2019;68(8):1420-1426 Abstract

46. EPIDEMIOLOGY OF HEPATITIS E VIRUS INFECTION IN A COHORT OF 4,023 IMMUNOCOMPROMISED PATIENTS. Harritshøj LH, Hother CE, Sengeløv H, Daugaard G, Sørensen SS, Jacobsen S, Perch M, Holm DK, Sækmose SG, Aagaard B, Erikstrup C, Hogema BM, Lundgren JD, Ullum H.
Int J Infect Dis. 2019. pii: S1201-9712(19)30453-9. Abstract

47. Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study – 2012 – 2015. Raben D, Sullivan AK, Mocroft A, Kutsyna G, Hadžiosmanović V, et al., on behalf of the HIDES Study Group.
PLoS One. 2019;14(8):e0220108. Abstract

48. Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies. Wandeler G, Mauron E, Atkinson A, Dufour JF, Kraus D, Reiss P, Peters L, Dabis F, Fehr J, Bernasconi E, van der Valk M, Smit C, Gjærde LK, Rockstroh J, Neau D, Bonnet F, Rauch A; Swiss HIV Cohort Study, Athena Observational Cohort Study, EuroSIDA, ANRS CO3 Aquitaine Cohort.
J Hepatol. 2019;71(2):274-280. Abstract

49. Incomplete ART adherence is associated with higher inflammation in individuals who achieved virologic suppression in the START study. Castillo-Mancilla JR, Phillips AN, Neaton JD, Neuhaus J, Sharma S, Baker JV, Collins S, Mannheimer S, Pett S, Touzeau-Römer V, Polizzotto MN, Lundgren JD, Gardner EM; INSIGHT START Study Group.
J Int AIDS Soc. 2019;22(6):e25297. Abstract

50. Risk Factors for Failure of Primary (Val)ganciclovir Prophylaxis Against Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients. Khurana MP, Lodding IP, Mocroft A, Sørensen SS, Perch M, Rasmussen A, Gustafsson F, Lundgren JD.
Open Forum Infect Dis. 2019;6(6):ofz215. Abstract

51. The EuroSIDA study: 25 years of scientific achievements. K Laut, O Kirk, J Rockstroh ,A Phillips, B Ledergerber, J Gatell B Gazzard, A Horban, I Karpov, M Losso, A d’Arminio Monforte, C Pedersen, M Ristola, P Reiss, AU Scherrer, S de Wit, I Aho, LD Rasmussen, V Svedhem, G Wandeler, C Pradier, N Chkhartishvili, R Matulionyte, C Oprea, JD Kowalska, J Begovac, JM Miró, G Guaraldi, R Paredes, D Raben, D Podlekareva, L Peters, JD Lundgren, A Mocroft for the EuroSIDA study.
HIV Med. 2019. Abstract

52. Identifying cross-disease components of genetic risk across hospital data in the UK Biobank. Cortes A, Albers PK, Dendrou CA, Fugger L, McVean G.
Nature Genetics (2019) Abstract


1. Abacavir use and risk of recurrent myocardial infarction. Sabin CA, Ryom L , d'Arminio Monforte A, Hatleberg CI, Pradier C, El-Sadr W, Kirk O, Weber R ,Phillips AN,  Mocroft A,  Bonnet F,  Law M, de Wit S, Reiss P, Lundgren JD; D:A:D Study Group.
AIDS. 2018;32(1):79-88. Abstract

2. Airflow limitation in people living with HIV and matched uninfected controls. Ronit A, Lundgren J, Afzal S, Benfield T, Roen A, Mocroft A, Gerstoft J, Nordestgaard BG, Vestbo J, Nielsen SD; Copenhagen Co-morbidity in HIV infection (COCOMO) study group.
Thorax. 2018 [Epub ahead of print] Abstract

3. Cytomegalovirus Viral Load in Bronchoalveolar Lavage to Diagnose Lung Transplant Associated CMV Pneumonia. Lodding IP, Schultz HH, Jensen JU, Kirkby N, Perch M, Andersen C, Lundgren JD, Iversen M.
Transplantation. 2018;102(2):326-332. Abstract

4. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens. Cozzi-Lepri A, Zangerle R, Machala L, Zilmer K, Ristola M, Pradier C,Kirk O, Sambatakou H, Fätkenheuer G, Yust I, Schmid P, Gottfredsson M, Khromova I, Jilich D, Flisiak R, Smidt J, Rozentale B, Radoi R, Losso MH, Lundgren JD, Mocroft A; EuroSIDA Study Group.
HIV Med. 2018;19(2):102-117. Abstract

5. Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) Study. Ronit A, Sharma S, Baker JV, Mngqibisa R, Delory T, Caldeira L, Ndembi N, Lundgren JD, Phillips AN; International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) Strategic Timing of Antiretroviral Treatment (START) Study Group
J Infect Dis. 2018;217(3):405-412. Abstract 

6. The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people. Shepherd L, Borges ÁH, Harvey R, Bower M, Grulich A, Silverberg M, Weber J, Ristola M, Viard JP, Bogner JR, Gargalianos-Kakolyris P, Mussini C, Mansinho K, Yust I, Paduta D, Jilich D, Smiatacz T, Radoi R, Tomazic J, Plomgaard P, Frikke-Schmidt R, Lundgren J, Mocroft A; EuroSIDA in EuroCOORD.
HIV Med. 2018;19(2):90-101. Abstract

7.  Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV? Mocroft A, Laut K, Reiss P,Gatell J, Ormaasen V, Cavassini M, Hadziosmanovic V, Mansinho K, Pradier C, Vasylyev M, Mitsura V, Vandekerckhove L, Ostergaard L, Clarke A, Degen O,  Mulcahy F, Castagna A,, Sthoeger Z, Flamholc L, Sedláček D, Mozer-Lisewska I, Lundgren JD; EuroSIDA Study.
AIDS. 2018 ;32(2):205-215. Abstract

8. Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial. Molina JM, Grund B, Gordin F, Williams I, Schechter M, Losso M, Law M, Ekong E, Mwelase N, Skoutelis A, Wiselka MJ, Vandekerckhove L, Benfield T, Munroe D, Lundgren JD, Neaton JD; INSIGHT START study group
Lancet HIV. 2018  [Epub ahead of print]. Abstract

9. Cytomegalovirus (CMV) Disease Despite Weekly Preemptive CMV Strategy for Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation.
IP Lodding , C da Cunha Bang, SS Sørensen, F Gustafsson, M Iversen, N Kirkby, M Perch, A Rasmussen, H Sengeløv, A Mocroft, JD Lundgren.
Open Forum Infect Dis. 2018;5(5) Abstract

10. The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients. NE Wareham , A Mocroft, H Sengeløv, C Da Cunha-Bang, F Gustafsson, C Heilmann, M Iversen, NS Kirkby, A Rasmussen, SS Sørensen, JD Lundgren; MATCH in PERSIMUNE study group.
J Cancer Res Clin Oncol. 2018. Abstract

11. Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic. L Simonsen, E Higgs , RJ Taylor, D Wentworth, A Cozzi-Lepri, S Pett, DE Dwyer, R Davey, R Lynfield, M Losso, K Morales, MJ Glesby, J Weckx, D Carey, C Lane, J Lundgren; INSIGHT FLU002 and FLU003 Study Groups.
Clin Infect Dis. 2018. Abstract

12. Classification of death causes after transplantation (CLASS): Evaluation of methodology and initial results. NE Wareham, C Da Cunha-Bang, AH Borges, C Ekenberg, J Gerstoft, F Gustafsson, D Hansen, C Heilmann, M Helleberg, J Hillingsø, PS Krohn, IP Lodding, TK Lund, L Lundgren, A Mocroft, M Perch, SL Petersen, I Petruskevicius, A Rasmussen, K Rossing, AA Rostved,  H Sengeløv, VR Sørensen, SS Sørensen, JD Lundgren.
Medicine (Baltimore). 2018;97(29) Abstract

13. Automated oxygen control with O2matic® during admission with exacerbation of COPD Hansen EF, Hove JD, Bech CS, Jensen JS, Kallemose T, Vestbo J.
Int J Chron Obstruct Pulmon Dis. 2018 Dec 14;13:3997-4003. Abstract

14. Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort. Pelchen-Matthews A, Ryom L, Borges ÁH, Edwards S, Duvivier C, Stephan C, Sambatakou H, Maciejewska K, Portu JJ, Weber J, Degen O, Calmy A, Reikvam DH, Jevtovic D, Wiese L, Smidt J, Smiatacz T, Hassoun G, Kuznetsova A, Clotet B, Lundgren J, Mocroft A; EuroSIDA study.
AIDS. 2018.  [Epub ahead of print]. Abstract

15. Association between exposure to antiretroviral drugs and the incidence of hypertension in HIV-positive persons: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Hatleberg CI, Ryom L, d'Arminio Monforte A, Fontas E, Reiss P, Kirk O, El-Sadr W, Phillips A, de Wit S, Dabis F, Weber R, Law M, Lundgren JD, Sabin C; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group.
HIV Med. 2018 Oct;19(9):605-618.. Epub 2018. Abstract

16. Associations between serum albumin and serious non-AIDS events among people living with HIV. Ronit A, Hatleberg CI, Ryom L, Bonnet F, El-Sadr W, Reiss P, Weber R, Pradier C, De Wit S, Law M, d'Arminio Monforte A, Lundgren J, Mocroft A, Phillips AN, Sabin CA; D:A:D Study Group.
AIDS. 2018;32(13):1837-1848. Abstract

17. Body Mass Index and the Risk of Serious Non-AIDS Events and All-Cause Mortality in Treated HIV-Positive Individuals: D: A: D Cohort Analysis. Achhra AC,, Sabin C, Ryom L, Hatleberg C, Antonella dʼAminio M, de Wit S, Phillips A, Pradier C, Weber R, Reiss P, El-Sadr W, Bonnet F, Mocroft A, Lundgren J, Law MG; D:A:D Study Group.
J Acquir Immune Defic Syndr. 2018 ;78(5):579-588. Abstract

18. Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study. Ryom L, Lundgren JD, El-Sadr W, Reiss P, Kirk O, Law M, Phillips A, Weber R, Fontas E, d' Arminio Monforte A, De Wit S, Dabis F, Hatleberg C, Sabin C, Mocroft A; D:A:D study group.
Lancet HIV. 2018 ;5(6):e291-e300. Abstract

19. Development and Validation of a Risk Score for Febrile Neutropenia After Chemotherapy in Patients With Cancer: The FENCE Score Theis Aagaard, Ashley Roen, Joanne Reekie, Gedske Daugaard, Peter de Nully Brown, Lena Specht, Henrik Sengeløv, Amanda Mocroft, Jens Lundgren, Marie Helleberg.
JNCI Cancer Spectrum, Volume 2, Issue 4, 1 November 2018, pky053 Article

20. Computed tomography quantification of emphysema in people living with HIV and uninfected controls. Ronit A, Kristensen T, Hoseth VS, Abou-Kassem D, Kühl JT, Benfield T, Gerstoft J, Afzal S, Nordestgaard BG, Lundgren JD, Vestbo J, Kofoed KF, Nielsen SD; Copenhagen Comorbidity in HIV Infection (COCOMO) study group.
 Eur Respir J. 2018, 52(1).  Abstract

21. Contemporary protease inhibitors and cardiovascular risk. Lundgren J, Mocroft A, Ryom L.
Curr Opin Infect Dis. 2018;31(1):8-13. Abstract

22. C-Reactive Protein Levels at Diagnosis of Acute Graft-versus-Host Disease Predict Steroid-Refractory Disease, Treatment-Related Mortality, and Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation. Minculescu L, Kornblit BT, Friis LS, Schiødt I, Petersen SL, Andersen NS, Sengeloev H.
Biol Blood Marrow Transplant. 2018;24(3):600-607. Abstract

23. Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America. Caro-Vega Y, Schultze A, W Efsen AM, Post FA, Panteleev A, Skrahin A, Miro JM, Girardi E, Podlekareva DN, Lundgren JD, Sierra-Madero J, Toibaro J, Andrade-Villanueva J, Tetradov S, Fehr J, Caylà J, Losso MH, Miller RF, Mocroft A, Kirk O, Crabtree-Ramírez B.
BMC Infect Dis. 2018;18(1):191.

24. Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma. Shepherd L, Ryom L, Law M, Hatleberg CI, de Wit S, Monforte AD, Battegay M, Phillips A, Bonnet F, Reiss P, Pradier C, Grulich A, Sabin C, Lundgren J, Mocroft A.
J Natl Cancer Inst. 2018;110(6):598-607. Abstract

25. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bucher HC, Annane D, Reinhart K, Falsey AR, Branche A, Damas P, Nijsten M, de Lange DW, Deliberato RO, Oliveira CF, Maravić-Stojković V, Verduri A, Beghé B, Cao B, Shehabi Y, Jensen JS, Corti C, van Oers JAH, Beishuizen A, Girbes ARJ, de Jong E, Briel M, Mueller B.
Lancet Infect Dis. 2018 Jan;18(1):95-107. Article

26. Fluid accumulation during acute kidney injury in the intensive care unit. Berthelsen RE, Perner A, Jensen AK, Jensen JU, Bestle MH.
Acta Anaesthesiol Scand. 2018 Jul;62(6):780-790. Abstract

27. Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study. Hatleberg CI, Ryom L, El-Sadr W, Mocroft A, Reiss P, De Wit S, Dabis F, Pradier C, d'Arminio Monforte A, Kovari H, Law M, Lundgren JD, Sabin CA; Data Collection of Adverse Events of Anti-HIV drugs (D:A:D) Study group.
J Int AIDS Soc. 2018, 21(3). Abstract

28. HIV infection is independently associated with a higher concentration of alpha-1 antitrypsin. Thudium RF, Lundgren J, Benfield T, Nordestgaard BG, Borges ÁH, Gerstoft J, Nielsen SD, Ronit A; Copenhagen Co-morbidity in HIV Infection (COCOMO) Study Group.
HIV Med. 2018  [Epub ahead of print]. Abstract

29. Induced hypothermia in patients with septic shock and respiratory failure (CASS): a randomised, controlled, open-label trial. Itenov TS, Johansen ME, Bestle M, Thormar K, Hein L, Gyldensted L, Lindhardt A, Christensen H, Estrup S, Pedersen HP, Harmon M, Soni UK,  Perez-Protto S, Wesche N, Skram U, Petersen JA, Mohr T, Waldau T, Poulsen LM, Strange D, Juffermans NP9, Sessler DI12, Tønnesen E, Møller K, Kristensen DK, Cozzi-Lepri A, Lundgren JD, Jensen JU; Cooling and Surviving Septic Shock (CASS) Trial Collaboration.
Lancet Respir Med. 2018;6(3):183-192. Epub 2018. Abstract

30. No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell counts. Wright EJ, Grund B, Robertson KR, Cysique L, Brew BJ, Collins GL, Poehlman-Roediger M, Vjecha MJ, Penalva de Oliveira AC, Standridge B, Carey C, Avihingsanon A, Florence E, Lundgren JD, Arenas-Pinto A, Mueller NJ, Winston A, Nsubuga MS, Lal L, Price RW; INSIGHT START Neurology Substudy Group.
AIDS. 2018;32(8):985-997. Abstract

31. Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015. Laut K, Shepherd L, Radoi R, Karpov I, Parczewski M, Mussini C, Maltez F, Losso M, Chkhartishvili N, Elinav H, Kovari H, Blaxhult A, Zangerle R, Trofimova T, Inglot M, Zilmer K, Kuzovatova E, Staub T, Raben D, Lundgren J, Mocroft A, Kirk O, On Behalf Of The EuroSIDA Study Group.
Euro Surveill. 2018;23(21). Abstract 

32. Predicting recovery from acute kidney injury in critically ill patients: development and validation of a prediction model.  Itenov TS, Berthelsen RE, Jensen JU, Gerds TA, Pedersen LM, Strange D, Thormar K, Løken J, Andersen MH, Tousi H, Reiter N, Lundgren JD, Bestle MH; Procalcitonin and Survival Study Group.
Crit Care Resusc. 2018;20(1):54-60. Abstract

33. Prevalence of Peripheral Artery Disease is Higher in Persons Living with HIV Compared to Uninfected Controls. Knudsen AD, Gelpi M, Afzal S, Ronit A, Roen A, Mocroft A, Lundgren J, Nordestgaard B, Sillesen H, Lebech AM6, Køber L, Kofoed KF, Nielsen SD.
J Acquir Immune Defic Syndr. 2018 [Epub ahead of print] Abstract

34. Prevention of HIV transmission by antiretroviral therapy. Lundgren J, Phillips A.
 Lancet HIV. 2018 5(3):e108-e109. Abstract

35. Multiple Homozygous Variants in the STING-Encoding TMEM173 Gene in HIV Long-Term Nonprogressors. Nissen SK, Pedersen JG, Helleberg M, Kjær K, Thavachelvam K, Obel N, Tolstrup M, Jakobsen MR, Mogensen TH.
J Immunol. 2018 May 15;200(10):3372-3382. Abstract

36. Sepsis: Personalized Medicine Utilizing 'Omic' Technologies-A Paradigm Shift? Itenov TS, Murray DD, Jensen JUS.
Healthcare (Basel). 2018;6(3). Abstract

37. Serious Non-AIDS Conditions in HIV: Benefit of Early ART. Lundgren JD, Borges AH, Neaton JD.
Curr HIV/AIDS Rep. 2018;15(2):162-171. Abstract

38. Privatisation rescues function following loss of cooperation. Andersen SB, Ghoul M, Marvig RL, Lee ZB, Molin S, Johansen HK, Griffin AS.
Elife. 2018 Dec 18;7. pii: e38594. Abstract

39. Whole Exome Sequencing of HIV-1 long-term non-progressors identifies rare variants in genes encoding innate immune sensors and signaling molecules. Nissen SK, Christiansen M, Helleberg M, Kjær K, Jørgensen SE, Gerstoft J, Katzenstein TL, Benfield T, Kronborg G, Larsen CS, Laursen A, Pedersen G, Jakobsen MR, Tolstrup M, Mogensen TH.
Sci Rep. 2018 Oct 15;8(1):15253. Abstract

40. The association between detected drug resistance mutations and CD4+ T-cell decline in HIV-positive individuals maintained on a failing treatment regimen. Schultze A, Paredes R, Sabin C, Phillips AN, Pillay D, Mackie N, Castagna A, Chadwick D, Falconer K, Geretti AM, Post FA, Hill T, Kirk O, Pozniak A, Nelson M, Tostevin A, Dunn D, Lundgren J, Cozzi-Lepri A.
Antivir Ther. 2018;23(2):105-116. Abstract

41. The HepHIV 2017 Conference in Malta: joining forces for the earlier diagnosis of HIV and viral hepatitis. Raben D, Hoekstra M, Sperle I, Amato Gauci AJ, Gauci C, West B, Sullivan A, Lazarus JV, Platteau T, Rockstroh JK; HepHIV Conference Organising Committee and the HIV in Europe Steering Committee.
HIV Med. 2018
;19 Suppl 1:5-10. Abstract

42. Uptake of hepatitis C virus treatment in HIV/hepatitis C virus-coinfected patients across Europe in the era of direct-acting antivirals. Peters L, Laut K, Resnati C, Del Campo S, Leen C, Falconer K, Trofimova T, Paduta D, Gatell J, Rauch A, Lacombe K, Domingo P, Chkhartishvili N, Zangerle R, Matulionyte R, Mitsura V, Benfield T, Zilmer K, Khromova I, Lundgren J, Rockstroh J, Mocroft A; EuroSIDA Study Group.
AIDS. 2018;32(14):1995-2004. Abstract 

43. Uptake of tenofovir-based antiretroviral therapy among HIV-HBV-coinfected patients in the EuroSIDA study. Peters L, Mocroft A, Grint D, Moreno S, Calmy A, Jevtovic D, Sambatakou H, Lacombe K, De Wit S, Rockstroh J Smidt J, Karpov I, Grzeszczuk A, Haziosmanovic V, Gottfredsson M, Radoi R, Kuzovatova E, Orkin C, Ridolfo AL, Zapirain J, Lundgren J.
Antivir Ther. 2018 [Epub ahead of print] Abstract

44. Incidence and predictors of infection among patients prior to treatment of chronic lymphocytic leukemia: a Danish nationwide cohort study. Andersen MA, Eriksen CT, Brieghel C, Biccler JL, Cunha-Bang CD, Helleberg M, Niemann CU.
Haematologica. 2018;103(7):e300-e303. Abstract

45. In silico thrombin generation: Plasma composition imbalance and mortality in human immunodeficiency virus. Kathleen E. Brummel-Ziedins PhD, Matthew Gissel MS, Jacqueline Neuhaus MS, Álvaro H. Borges MD, MSc, PhD, David R. Chadwick MRCP, PhD, Sean Emery PhD, James D. Neaton PhD, Russell P. Tracy PhD, Jason V. Baker MD, MS, for the INSIGHT SMART, ESPRIT Study Groups
Res Pract Thromb Haemost. 2 0 1 8 ;1–10 . Article

46. HLA variation and disease. Dendrou CA, Petersen J, Rossjohn J, Fugger L.
Nat Rev Immunol. 2018;18(5):325-339. Abstract

47. Higher Risk of Abdominal Obesity, Elevated Low-Density Lipoprotein Cholesterol, and Hypertriglyceridemia, but not of Hypertension, in People Living With Human Immunodeficiency Virus (HIV): Results From the Copenhagen Comorbidity in HIV Infection Study. Gelpi M, Afzal S, Lundgren J, Ronit A, Roen A, Mocroft A, Gerstoft J, Lebech AM, Lindegaard B, Kofoed KF, Nordestgaard BG, Nielsen SD.
Clin Infect Dis. 2018;67(4):579-586. Abstract

48. Febrile Neutropenia and Long-term Risk of Infection Among Patients Treated With Chemotherapy for Malignant Diseases.
Nordvig J, Aagaard T, Daugaard G, Brown P, Sengeløv H, Lundgren J, Helleberg M.
Open Forum Infect Dis. 2018 5(10). Abstract

49. Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trials. Schuetz P, Bolliger R, Merker M, Christ-Crain M, Stolz D, Tamm M, Luyt CE, Wolff M, Schroeder S, Nobre V, Reinhart K, Branche A, Damas P, Nijsten M, Deliberato RO, Verduri A, Beghé B, Cao B, Shehabi Y, Jensen JS, Beishuizen A, de Jong E, Briel M, Welte T, Mueller B.
Expert Rev Anti Infect Ther. 2018 Jul;16(7):555-564. Abstract

50. Procalcitonin-guided antibiotic treatment in patients with positive blood cultures: A patient-level meta-analysis of randomized trials. Meier MA, Branche A, Neeser OL, Wirz Y, Haubitz S, Bouadma L, Wolff M, Luyt CE, Chastre J, Tubach F, Christ-Crain M, Corti C, Jensen JS, Deliberato RO, Kristoffersen KB, Damas P, Nobre V, Oliveira CF, Shehabi Y, Stolz D, Tamm M, Mueller B, Schuetz P.
Clin Infect Dis. 2018 Oct 25. Abstract

51. Forced fluid removal versus usual care in intensive care patients with high-risk acute kidney injury and severe fluid overload (FFAKI): study protocol for a randomised controlled pilot trial.  RE Berthelsen, T Itenov, A Perner, JU Jensen, M Ibsen, AEK Jensen, M Bestle
Trials. 2017 ;18(1):189. Abstract


1. Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial. J O'Connor, MJ Vjecha, AN Phillips, B Angus, D Cooper, B Grinsztejn, G Lopardo, S Das, R Wood, A Wilkin, H Klinker, P Kantipong, KL Klingman, D Jilich, E Herieka, E Denning, I Abubakar, F Gordin, JD Lundgren; INSIGHT START study group.
Lancet HIV. 2017, 4(3) e105-e112. Abstract

2. Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials. P Ljungman, M Boeckh, HH Hirsch, F Josephson, J Lundgren, G Nichols, A Pikis, RR Razonable, V Miller, PD Griffiths; Disease Definitions Working Group of the Cytomegalovirus Drug Development Forum.
Clin Infect Dis. 2017 ;64(1):87-91. Epub 2016 Sep 28. Abstract

3. An epidemiological modelling study to estimate the composition of HIV-positive populations including migrants from endemic settings. 
F Nakagawa, V Delpech, J Albert, A Alioum, D Bezemer, M Cortina-Borja, AE Brown, V Cambiano, C Campbell, D Costagliola, A de Luca, R Kouyos, R Lodwick, JD Lundgren, N Pantazis, C Smith, V Supervie, P Tookey, G Touloumi, Zh Yin, A van Sighem, AN Phillips
AIDS. 2017 ;31(3):417-425. Abstract

4. One-year mortality of HIV-positive patients treated for rifampicin- and isoniazid- susceptible tuberculosis in Eastern Europe, Western Europe and Latin America. D.N. Podlekareva, A. Schultze, A. Panteleev, A.M. Skrahina, J.M. Miro,  A. Rakhmanova†, H. Furrer, R.F Miller, A.M. W. Efsen, M.H. Losso, J. Toibaro, A. Vassilenko, E. Girardi, J.D. Lundgren, A. Mocroft, F.A. Post, O. Kirk, on behalf of the TB:HIV study group in EuroCoord.
AIDS. 2017;31(3):375-384. Abstract

5. The clinical utility of PDG PET/CT among solid organ transplant recipients suspected of malignancy or infection. NE Wareham, JD Lundgren, C Da Cuncha-Bang, F Gustafsson, M Iversen, HH Johannesen, A Kjær, A Rasmussen, H Sengeløv, SS Sørensen, BM Fischer.
Eur J Nucl Med Mol Imaging. 2017. Abstract

6. Combination antiretroviral therapy and cancer risk. AH Borges
Current opinion in HIV & AIDS 2017, Vol 11 (6) iv-iv 545-627. Abstract

7. Antiretrovirals, fractures and osteonecrosis in a large international HIV cohort. AH Borges,J Hoy, E Florence, D Sedlacek, HJ Stellbrink, V Uzdaviniene, J Tomazic, P Gargalianos-Kakolyris, P Schmid, C Orkin, C Pedersen, C Leen, C Pradier, F Mulcahy, AL Ridolfo, T Staub, F Maltez, R Weber, L Flamholc, G Kyselyova JD Lungren, A Mocroft; for EuroSIDA.
Clin Infect Dis 2017. Abstract

8. Late presentation of chronic viral hepatitis for medical care: a consensus definition. S Mauss, S Pol, M Buti , E Duffell, C Gore, JV Lazarus ,HL  der Grient, J Lundgren, A Mozalevskis, D Raben, E Schatz, S Wiktor, JK Rockstroh; European consensus working group on late presentation for Viral Hepatitis Care.
BMC Medicine 2017; 15(1):92. Abstract

9. Endothelial Damage Signals Refractory Acute Kidney Injury in Critically Ill Patients. TS Itenov, JU Jensen, SR Ostrowski, PI Johansson, KM Thormar, JD Lundgren, MH Bestle; “Procalcitonin And Survival Study” study group.
Shock 2017, 47(6) 696-701. Abstract

10. Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV-Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial. JV Baker, S Sharma, AC Achhra, JI Bernardino, JR Bogner,  D Duprez, S Emery, B Gazzard, J Gordin, G Grandits, AN Phillips, S Schwarze, EZ Soliman, SA Spector, G Tambussi, J Lundgren; INSIGHT (International Network for Strategic Initiatives in Global HIV Trials) START (Strategic Timing of Antiretroviral Treatment) Study Group.
Journal of the American Heart Association 2017; 6(5). Abstract 

11. Evaluation of HIV testing recommendations in specialty guidelines for the management of HIV indicator conditions. E Lord, AJ Stockdale, R Malek, C Rae, I Sperle, D Raben, A Freedman, D Churchill, J Lundgren, AK Sullivan; British Association of Sexual Health HIV (BASHH)/British HIV Association (BHIVA) guideline review group for the Optimising Testing and Linkage to Care for HIV across Europe (OptTEST) project by HIV in Europeb.
HIV Medicine 2017; 18(4): 300-304. Abstract

12. Bayesian analysis of genetic association across tree-structured routine healthcare data in the UK Biobank. A Cortes, CA Dendrou, A Motyer, L Jostins, D Vukcevic, A Dilthey,P Donnelly, S Leslie, L Fugger, G McVean.
Nat Genet. 2017;49(9):1311-1318. Abstract

13. Risk of infectious diseases among first-degree relatives of transplant recipients who develop CMV infection: is the infectious phenotype inheritable? C Ekenberg, IP Lodding, NE Wareham, SS Sørensen, H Sengeløv, F Gustafsson, A Rasmussen, M Perch, JD Lundgren, M Helleberg
Eur J Clin Microbiol Infect Dis. 2017. Abstract

14. Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial. Baker JV, Sharma S, Grund B, Rupert A, Metcalf JA, Schechter M, Munderi P, Aho I, Emery S, Babiker A, Phillips A, Lundgren JD, Neaton JD, Lane HC; INSIGHT START (Strategic Timing of AntiRetroviral Treatment) Study Group.
Open Forum Infect Dis. 2017;4(4). Abstract

15. Incidental lung cancers and positive computed tomography images in people living with HIV. A Ronit, T Kristensen, DM Klitbo, M Gelpi, A Kalhauge, T Benfield, J Gerstoft, J Lundgren, J Vestbo, KF Kofoed, SD Nielsen  
AIDS 2017; 31(14): 1973-1977.Abstract

16. Predictors of eGFR progression, stabilisation or improvement after chronic renal impairment in HIV-positive individuals.  LR Nielsen, A Mocroft, O Kirk, P Reiss, M Ross, C Smith, O Moranne, P Morlat, CA Fux, C Sabin, A Phillips, M Law, JD Lundgren. & D:A:D study group
AIDS 2017 Abstract 

17. Euroguidelines in Central and Eastern Europe (ECEE) conference and the Warsaw Declaration - a comprehensive meeting report. JD Kowalska, C Oprea, S de Witt,  A Pozniak , D Gökengin, M Youle, JD Lundgren, A Horban, & ECEE Network Group
HIV Med. 2017 May;18(5):370-375. Abstract

18. Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study. MA Boyd, A Mocroft, L Ryom, AD Monforte, C Sabin , WM El-Sadr,  CIHatleberg, S De Wit, R Weber, E Fontas, A Phillips, F Bonnet, P Reiss, J Lundgren, M Law.
PLoS Med. 2017 ;14(11):. eCollection 2017 Nov. Abstract

19. HIV testing in Europe: Evaluating the impact, added value, relevance and usability of the European Centre for Disease Prevention and Control (ECDC)'s 2010 HIV testing guidance. AK Sullivan, I Sperle, D Raben, AJ Amato-Gauci, JD Lundgren, Y Yazdanpanah, SF Jakobsen, L Tavoschi
Euro Surveill. 2017;22(48). Abstract 

20. Are we successfully managing cardiovascular disease in people living with HIV? CI Hatleberg, JD Lundgren, L Ryom.
Curr Opin HIV AIDS. 2017;12(6):594-603Abstract 

21. Global brain atrophy and metabolic dysfunction in LGI1 encephalitis: A prospective multimodal MRI study. M Szots, M Blaabjerg, G Orsi, P Iversen, D Kondziella, CG Madsen, E Garde, PO Magnusson, P Barsi, F Nagy, HR Siebner, Z Illes.
J Neurol Sci. 2017;376:159-165. Abstract

22. Forced fluid removal versus usual care in intensive care patients with high-risk acute kidney injury and severe fluid overload (FFAKI): study protocol for a randomised controlled pilot trial. RE Berthelsen, T Itenov, A Perner, JU Jensen, M Ibsen, AEK Jensen, M Bestle.
Trials. 2017 Apr 24;18(1):189. Abstract

23. Management of Respiratory Infections with Use of Procalcitonin: Moving toward More Personalized Antibiotic Treatment Decisions. Wirz Y, Branche A, Wolff M, Welte T, Nobre V, Reinhart K, Falsey AR, Damas P, Beishuizen A, Deliberato RO, Shehabi Y, Jensen JS, Mueller B, Schuetz P. 
ACS Infect Dis. 2017 Dec 8;3(12):875-879. Abstract

24. Plasma HIV-1 Tropism and the Risk of Short-Term Clinical Progression to AIDS or Death. M Casadellà, A Cozzi-Lepri, A Phillips, M Noguera-Julian, M Bickel, D Sedlacek, K Zilmer, B Clotet, JD Lundgren, R Paredes. EuroSIDA in EuroCOORD.
PLoS One. 2017 Jan 27;12(1):e0166613. Abstract 

25. Self-Rated Health as a Predictor of Death after Two Years: The Importance of Physical and Mental Wellbeing Postintensive Care. Vejen M, Bjorner JB, Bestle MH, Lindhardt A, Jensen JU.
Biomed Res Int. 2017; 2017: 5192640. Abstract 

26. Small airway dysfunction in well-treated never-smoking HIV-infected individuals. A Ronit, IH Mathiesen, M Gelpi, T Benfield, J Gerstoft, T Pressler, A Christiansen, J Lundgren, J Vestbo, S Dam Nielsen.
Eur Respir J. 2017 Mar 2;49(3). pii: 1602186. Article


  1. Antiretroviral drugs and risk of chronic ALT elevation in HIV-infected persons without viral hepatitis coinfection. The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study H Kovari, CA Sabin, B Ledergerber, L Ryom, P Reiss, M Law, C Pradier, F Dabis, A d’Arminio Monforte, C Smith, S de Wit, O Kirk, JD Lundgren, R Weber , on behalf of the D:A:D Study group. 
    Open Forum Infect Dis. 2016 ;3(1):ofw009. Abstract
  2. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study. A Mocroft, JD Lundgren, M Ross, CA Fux  P Reiss, O Moranne, P Morlat, A d'Arminio Monforte, O Kirk, L Ryom, on behalf of The Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) Study. 
    Lancet HIV. 2016 ;3(1):e23-32. Abstract
  3. Tuberculosis-related mortality in people living with HIV In Europe and Latin America: an international cohort study. Daria Podlekareva, Anne Marie W. Efsen, Anna Schultze, Frank Post,, Alena M. Skrahina, Alexander Panteleev, Hansjakob Furrer, Robert F. Miller, Marcelo H. Losso, Javier Toibaro, Jose M. Miro, Anna Vassilenko, Enrico Girardi, Mathias Bruyans, Niels Obel, Jens D. Lundgren, Amanda Mocroft, Ole kirk on behalf of the TB:HIV study group in EuroCoord. 
    Lancet HIV. 2016 ;3(3):e120-31. Abstract
  4. Identifying key drivers of the impact of an HIV cure intervention in sub-Saharan Africa. A Phillips A, Cambiano, P Revill , F Nakagawa, J Lundgren, L Bansi-Matharu, T Mabugu, M Sculpher, G Garnett, S Staprans, S Becker, J Murungu, SR Lewin, SG Deeks, T Hallett T.*
    J Infect Dis. 2016. 214(1) 73-9. Abstract
  5. Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials. AH Borges, A Lundh, B Tendal, JA Bartlett, N Clumeck, D Costagliola,ES Daar, P Echeverría, M Gisslén, TB Huedo-Medina, MD Hughes, K Huppler Hullsiek, P Khabo, S Komati, P Kumar, S Lockman, RD MacArthur, F Maggiolo, A Matteelli, JM Miro, S Oka, K Petoumenos, RL Puls, SA Riddler, PE Sax, J Sierra-Madero, C Torti, JD Lundgren.
    Clin Infect Dis. 2016. 63(2) 268-280.  Abstract
  6. IL-6 is a stronger predictor of clinical events than hsCRP or D-dimer during HIV infection. AH Borges,JL O'Connor, AN Phillips, JD Neaton, B Grund, J Neuhaus, MJ Vjecha, A Calmy, KK Koelsch, JD Lundgren; INSIGHT SMART ESPRIT Study Groups.
    J Infect Dis. 2016. 214(3) 408-416 . Abstract 
  7. Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study. Amit C Achhra; Amanda Mocroft; Peter Reiss; Caroline Sabin; Lene Ryom; Stephane de Wit; Colette J Smith; Antonella d´arminio Monforte; Andrew Phillips; Rainer Weber;  Jens Lundgren;  Matthew G Law; The D:A:D Study Group.
    HIV Med. 2016 (4):255-68. Abstract
  8. MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year. AA Rostved, JD Lundgren, J Hillingsø , L Peters, A Mocroft, A Rasmussen.
    Scand J Gastroenterol. 2016, 51 (11), 1360-1366. Abstract
  9. Is Nelfinavir Exposure Associated with Cancer Incidence in HIV-positive individuals? DC Boettinger, CA Sabine, A grulich, L Ryom, F Bonnet, P Reiss, A d'Arminio Monforte, O Kirk, A Phillips, M Bower, G Fätkenheuer, JD Lundgren, M Law. On behalf of the Data collection on Adverse events of Anti-HIV Drugs (D:A:D) study group
    AIDS. 2016 ;30(10):1629-37. Abstract
  10. Immediate antiretroviral therapy reduces risk of infection-related cancer during early HIV infection. AH Borges, J Neuhaus, AG Babiker, K Henry, MK Jain, A Palfreeman, P Mugyenyi, P Domingo, C Hoffmann, TR Read, S Pujari, M Meulbroek, M Johnson, T Wilkin, R Mitsuyasu. INSIGHT START study Group
    Clin Infect Dis 2016.63(12) 1668-1676. Abstracts
  11. Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study. Gjærde LI, Shepherd L Jablonowska E, Lazzarin A, Rougemont M, Darling K, Battegay M, Braun D, Martel-Laferriere V, Lundgren JD, Rockstroh JK, Gill J, Rauch A, Mocroft A, Klein MB, Peters L. 
    Clin Infect Dis. 2016 ;63(6):821-9. abstract
  12. Renal Impairment and Cardiovascular Disease in HIV-positive Individuals; The D:A:D Study. L Ryom, JD  Lundgren, M Ross, O  Kirk, M  Law, P Morlat, C Smit, E Fontas, CA  Fux, CI  Hatleberg, S de Wit, CA Sabin and A Mocroft for the D:A:D Study Group
    J Infect Dis. 2016 ;214(8):1212-20. Abstract
  13. Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy AJ. Rodger V Cambiano, T Bruun, P Vernazza, S Collins; J van Lunzen, GM Corbelli; V Estrada, AM Geretti, A Beloukas, D Asboe, P Viciana, F Gutiérrez, B Clotet, C Pradier, J Gerstoft, R Weber, K Westling, G Wandeler, JM. Prins,  A  Rieger, M Stoeckle, T Kümmerle, T Bini,  A Ammassari, R Gilson, I Krznaric,M Ristola, R Zangerle, P Handberg, A Antela, S Allan,  A N. Phillips, J Lundgren, for the PARTNER Study Group 
    JAMA. 2016;316(2):171-181. Abstract
  14. Disparities in HIV clinic care across Europe: findings from the EuroSIDA clinic survey.  JV Lazarus, K Laut, K Safreed-Harmon, L Peters, M Johnson, G Fätkenheuer, I Khromova, L Vandekerckhove, K Maciejewska, R Radoi, AL Ridolfo, A Mocroft, on behalf of EuroSIDA in EuroCoord. 
    BMC Infectious Diseases 2016 16:335. Article
  15. Associations between HIV-RNA-based indicators and virological and clinical outcomes. K Laut, L Shepherd, C Pedersen, JK Rockstroh, H Sambatakou, D Paduta, R Matulionyte, T Smiatacz, F Mulcahy, JD Lundgren, A Mocroft, O Kirk, on behalf of EuroSIDA in EuroCoord.
    AIDS 2016;30(12):1961-72. abstract
  16. Prediction of non-recovery from ventilator-demanding acute respiratory failure, ARDS and death using lung damage biomarkers: data from a 1200-patient critical care randomized trial. JS Jensen, TS Itenov, KM Thormar, L Hein ,TT Mohr, MH Andersen, J Løken, H Tousi, B Lundgren, HC Boesen, ME Johansen, SR Ostrowski, PI Johansson, J Grarup, J Vestbo, JD Lundgren; Procalcitonin And Survival Study (PASS) Group.
     Ann Intensive Care. 2016 ;6(1):114. Abstract

  17. Improvements over time in short-term mortality following myocardial infarctions in HIV-positive individuals. CI Hatleberg, L Ryom, W El-Sadr, C Smith, R Weber, P Reiss, E Fontas, F Dabis, M Law, A d'Arminio Monforte, S de Wit, A Mocroft, A Phillips, JD Lundgren, C Sabin. On behalf of the D:A:D Study Group.
    AIDS 2016, 30:1583-1596. Abstract 

  18. Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression: a prospective cohort study JM Llibre, A Cozzi-Lepri, C Pedersen, M Ristola, M Losso, A Mocroft, V Mitsura, K Falconer, F Maltez, M Beniowski, V Vullo, G Hassoun, E Kuzovatova, J Szlavik, A Kuznetsova, H-J Stellbrink, C Duvivier, S Edwards, K Laut, R Paredes for the EuroSIDA Study Group. 
    Medicine 2016, Volume 95(40), abstract
  19. The per-protocol effect of immediate versus deferred antiretroviral therapy initiation. S Lodi, S Sharma, JD Lundgren, AN Phillips, SR Cole, R Logan, BK Agan, A Babiker, H Klinker, H Chu, M Law, JD Neaton, MA Hernán, INSIGHT Strategic Timing of Antiretroviral Treatment (START) study group.
    AIDS 2016, 30(17) 2659-2663. Abstract 
  20. Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial. KM Kunisaki, DE Niewoehner, G Collins, B Aagaard, NB Atako, E Bakowska, A Clarke, GM Corbelli, E Ekong, S Emery, EB Finley, E Florence, RM Infante, CM Kityo, JS Madero, DE Nixon, E Tedaldi, J Vestbo, R Wood, JE Connett; INSIGHT START Pulmonary Substudy Group.
    Lancet Respir Med. 2016, 4(12) 980-989. Abstract
  21. Sepsis – frontiers in resuscitation and infection control. A Perner, AC Gordon, D de Backer, G Dimopoulos, JA Russell, J Lipman, JU Jensen, J Myburgh, M Singer, R Bellomo, T Walsh. 
    Intensive Care Medicine 2016;42(12):1958-1969. Abstract



  1. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D StudyA Mocroft, JD Lundgren, M Ross, M Law, P Reiss, O Kirk, C Smith, D Wentworth, J Neuhaus, C A. Fux, O Moranne, P Morlat, MA Johnson, L Ryom, D:A:D study group, the Royal Free Hospital Clinic Cohort, and the INSIGHT, SMART, and ESPRIT study groups 
    PLoS Med 2015, 12 (3)

  2. Clinical Application of Variation in Replication Kinetics During Episodes of Post-transplant Cytomegalovirus Infections, IP Lodding, H Sengeløv, C da Cunha-Bang, M Iversen, A Rasmussen, F Gustafsson, JG Downing, J Grarup, N Kirkeby, CM Frederiksen, A Mocroft, SS Sørensen, JD Lundgren,
    On behalf of the MATCH Programme Study Group
    EBioMedicine; 2015 Vol 2, Issue 7 p.669-705

  3. Factors Associated with Plasma IL-6 Levels During HIV Infection,  ÁH Borges, JL O'Connor, AN Phillips, FF Rönsholt, S Pett, MJ Vjecha, MA French, JD Lundgren, INSIGHT, SMART and ESPRIT Study Groups and the SILCAAT Scientific Committee
    J Infect Dis. 2015. 212, 585- 595

  4. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection, The INSIGHT START Study Group, JD Lundgren, AG Babiker , F Gordin, S Emery, B Grund, S Sharma, A Avihingsanon, DA Cooper, G Fätkenheuer, JM Llibre, J Molina, P Munderi, M Schechter, R Wood, KL Klingman, S Collins, HC Lane, AN Phillips, JD Neaton, The INSIGHT START Study Group 
    New England J Med 2015, 373: 795-807 
  5. Late presentation for HIV care across Europe: Update from the collaboration of observational HIV epidemiological research Europe (COHERE) Study 2010 to 2013, The late presenters working group in COHERE in EuroCoord,  A Mocroft et. al.
    Eurosurveillance 2015 Vol 20, Issue 47

  6. Sustainable HIV treatment in Africa through viral-load-informed differentiated care. Working Group on Modelling of Antiretroviral Therapy Monitoring Strategies in Sub-Saharan Africa, Phillips A, Shroufi A, Vojnov L, Cohn J, Roberts T, Ellman T, Bonner K, Rousseau C, Garnett G, Cambiano V, Nakagawa F, Ford D, Bansi-Matharu L, Miners A, Lundgren JD, Eaton JW, Parkes-Ratanshi R, Katz Z, Maman D, Ford N, Vitoria M, Doherty M, Dowdy D, Nichols B, Murtagh M, Wareham M, Palamountain KM, Chakanyuka Musanhu C, Stevens W, Katzenstein D, Ciaranello A, Barnabas R, Braithwaite RS, Bendavid E, Nathoo KJ, van de Vijver D, Wilson DP, Holmes C, Bershteyn A, Walker S, Raizes E, Jani I, Nelson LJ, Peeling R, Terris-Prestholt F, Murungu J, Mutasa-Apollo T, Hallett TB, Revill P. 
    Nature. 2015 ;528(7580):S68-76.